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Thesis Overview 
 
The accurate description and evaluation of the intermolecular 
interactions has a great importance in the molecular modelling of biological 
systems.  
Protein-protein interactions, in particular, being involved in virtually 
every cellular process, are nowadays the object of thorough studies aimed at the 
understanding and modulation of the underlying mechanism.  In the Part I of 
the present work, it will be shown how, through a computational approach, it is 
possible to get an in-depth analysis of the network of interactions occurring at 
the interface between tubulin subunits and how vinblastine, a commonly used 
anticancer agents, is able to interfere with the correct protein association, so 
having a therapeutic effect. In the Part II, the self-association of the bacterial 
protein FtsZ will be studied, showing that the detailed description of the 
protein-protein interactions can provide key information for the de-novo design 
of inhibiting molecules. 
Finally, in the Part II, the attention will be focused on the computational 
study of halogen bonding, which is found to have a great relevance in the 
recognition process between biological macromolecules and halogenated 
agents. In particular, it will be shown that a specific approach is mandatory for 
its correct description in the framework of the classical force-fields. 
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1.1 Protein-protein interactions 
Interactions between proteins are essential to a great number of 
biological processes, ranging from signal transduction to cell duplication. 
Disease-relevant protein-protein interactions occurring at defined cellular sites 
represent therefore a viable target in drug design which has lately gained an 
increasing interest as a therapeutic strategy and is presently one of the main 
goals of medicinal chemistry, as well as an active research field [1] [2] [3] . 
The leading force in protein-protein non-covalent association is 
hydrophobicity [4] [5] [6]. In fact, hydrophobic interactions occur between non-
polar side chains through van der Waals contacts, with a free energy gain due 
to their movement from the polar aqueous environment to the large nonpolar 
surface area that usually characterizes protein-protein interfaces. As a result, 
hydrophobic side chains from facing protein subunit form a tight packing that 
 Protein-protein interactions 
in computational chemistry 
Chapter 1 
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highly stabilizes the protein-protein complex [7]. Besides hydrophobic contacts, 
also electrostatic forces play a key role in the protein-protein association [8], 
acting as a steering force driving the complex formation according to 
electrostatic complementarity between the opposite subunits [9]. 
Nonetheless, the design of molecules inhibiting protein-protein 
interactions is a difficult task to achieve [10], mainly due to the fact that protein-
protein interfaces are large (1200-2000 Å2) [11] and mostly flat, thus not showing 
cavities where ligands could bind.   
It has been pointed out that, in general, only a minor part of the 
residues making up the interface actually contribute to the protein-protein 
binding energy [12] [13]. These critical amino acids, called hot-spots [14] [15], 
are thus to be targeted in order to interfere with the protein assembly process, 
so it might not be necessary for an inhibitor to cover the whole interface. Hot-
spots are usually grouped into small clusters and are found at the centre of a 
protein-protein interface, excluded by the solvent. Hot-spots are usually 
surrounded by a set of residues, called O-ring [15] [16], which are not 
energetically important for the protein-protein association, but have a key role 
in ensuring a complete exclusion from water. 
The prediction of the hot-spots location at a protein-protein interface is 
of utmost importance in protein engineering and in the structure-based drug 
design [17] [18] [19]. Experimentally, the identification of the hot-spots at a 
protein-protein interface can be performed through alanine scanning 
mutagenesis analysis [20]. Through alanine substitution, it is in fact possible to 
evaluate the role of the native side-chain functional groups and their energetic 
contribution to protein association, by estimating the difference in the binding 
energy of the complex before and after the mutation [21]. Glycine could replace 
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alanine, in principle, to nullify the side chains, but its use is limited by the 
conformational flexibility it could introduce into the protein backbone [22]. 
 
 
1.2 Computational evaluation of the binding 
free energy 
From an energetic point of view, residues are usually considered hot-
spots if the change in the binding free energy (ΔΔG) upon mutation into alanine 
is higher than 2 kcal/mol [23]. Nonetheless, the experimental estimation of the 
binding free energy may be a difficult task to achieve. Moreover, a mutagenesis 
study is time consuming and has a high cost. A computational approach in the 
calculation of the binding free energy between proteins, aimed at an in silico 
evaluation of the per-residue ΔΔG contributions, can be valuable in the 
understanding of the energetics of protein-protein assemblies [24] [25]. 
Different computational methods have been developed to estimate the 
binding free energy. Free energy perturbation [26] and thermodynamic 
integration [27] allow to obtain accurate estimates, but are computationally 
time-consuming and are not suitable for the study of large protein complexes. 
Other approximate methodologies have thus been proposed, such as Monte 
Carlo [28] and linear interactions energy methods [29]. 
In the present study, the MM-GBSA approach [30] was used for the 
evaluation of the binding free energy, which combines the molecular 
mechanical gas energies, the Generalized Born continuum solvation approach 
and the solvent accessibility method to treat the solvent effect to evaluate the 
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total free energies. The calculation of the binding free energy is performed a 
posteriori on snapshots extracted from a molecular dynamics simulation of the 
protein complex under examination. 
 
 
Figure 1 Thermodynamic cycle used in the MM-GBSA approach. 
 
The MM-GBSA approach uses a thermodynamic cycle (Figure 1) to 
calculate the binding free energy (ΔGAB,wat) between two protein subunits A and 
B in solution. Indicating with ΔGsolv the free energy of solvation as the 
difference between the free energy in solution (Gwat) and the free energy in 
vacuum (Ggas) 
 
                 
 
the free energy in solvent can be written as 
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As a result, the binding free energy for the complex AB in solution is 
 
                           
 
which corresponds to 
 
                                                
 
so decomposing the binding free energy in solvent into a vacuum term 
(ΔGAB,gas) and a solvation term (ΔΔGsolv). 
Dealing with snapshots extracted from a molecular dynamics trajectory, 
the equation above can be written as 
 
         〈    〉               
 
 
where  〈    〉 is the average molecular mechanics energy calculated during the 
simulation as the sum of intramolecular and intermolecular terms 
 
                                                   
 
 whereas TΔS is the entropic term.  
While the molecular mechanics energy term can be easily obtained from 
the results of a molecular dynamics simulation, the entropic term is often 
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difficult to achieve. The entropic term can thus be approximated to ΔSvib, i.e. the 
contribution due to the internal vibration, whose calculation is nonetheless 
usually time-consuming and can be performed only on part of the protein-
protein complex (see paragraph 3.2). In other cases, such as in the 
computational alanine scanning analyses, the entropic term can be neglected, as 
explained in the next paragraph. 
 The solvation term ΔΔGsolv is calculated a posteriori on the snapshots 
extracted from the molecular dynamics trajectory using an implicit solvent and 
is decomposed into an electrostatic and a non-electrostatic term. 
 The electrostatic term takes into account the contribution to the free 
energy due to the creation of a charge qi in a spherical cavity of radius ai in a 
solvent of dielectric constant ε. For N charges, located at an rij distance, the term 
can be calculated through the Generalized-Born equation: 
 
       
 
 
 (  
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The non-electrostatic term is calculated according to the Solvent Accessible 
Surface Area approach and is obtained through 
 
           
 
where γ and B are constants and A is the total solvent accessible surface. 
 
 
1.3 Computational alanine scanning 
 The calculation of the binding free energy allows to perform a 
computational alanine scanning of the protein-protein interface, in order to 
highlight the hot-spots, i.e. those residues which are particularly important for 
the subunits association [31] . The calculation is performed by evaluating the 
binding free energy between the protein subunits making up the complex 
(ΔGwild) and the binding energy upon mutation of each interfacial amino acid 
into an alanine (ΔGmut,X), so obtaining, for each residue, a ΔΔG value defined as 
 
                      
 
In this way, it is possible to evaluate the contribution of each amino acid to the 
total binding free energy, highlighting the hot-spots for which a ΔΔG higher 
than 2 kcal/mol is found [32] [33]. 
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 The relative contribution of the change in conformational entropy to the 
ΔΔG is considered to be negligible for the mutations studied, since it is 
supposed to cancel up when calculating it in the native and in the mutated 
complex. [34] 
 In the present work, the so-called single-trajectory approach was used 
when performing the computational alanine scanning. According to this 
procedure, a single molecular dynamics simulation is performed on the protein 
complex, using explicit or implicit solvent. A set of snapshots is then extracted 
from the trajectory for the ΔG evaluation. As to the monomers, it is not 
necessary to perform further molecular dynamics simulations, but snapshots 
are obtained from the same complex trajectory, by removing the partner 
subunit from the dimer structures taken into account. Such approach was 
proven to provide more reliable results with respect to other approaches where 
further molecular dynamics simulations are performed on the single monomers 
[35]. 
 In the Part I, the computational alanine scanning of the interface 
between tubulin units allowed an in-depth analysis of vinblastine antimitotic 
action. The same approach allowed, in the Part II, to highlight the main 
interactions between protein FtsZ monomers. 
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2.1 Microtubules structure and dynamics 
Microtubules [36] are hollow cylindrical structures which play an 
essential role in a great number of biological processes in eukaryotic cells. In 
fact, they act as a scaffold to determine the cell shape, allow the organelles 
transport through the cytoplasm and are responsible for the separation of the 
chromosomes during mitosis. Microtubules are made up of α-β tubulin 
heterodimers which assemble in a head-to-tail way to form protofilaments 
which later on associate laterally to give rise to cylindrical structures (Figure 2) 
[37] [38].  
Protofilament elongation, from the so-called minus-end to the plus-end, 
is closely related to the binding and hydrolysis of guanosine 5’-triphosphate 
Chapter 2 
Tubulin and microtubules 
Part I – Atomic-level analysis of vinblastine mechanism of action 
 
 
 
14 
 
(GTP) by tubulin [39]. Both α and β tubulin bind GTP, although GTP bound to 
α tubulin, at the interface between two monomers in the same dimer, is 
nonexchangeable, whereas the nucleotide bound to β tubulin, at the interface 
between two adjoining dimers, is exchangeable.  
The association between two tubulin dimers leads, after a short lag, to 
the hydrolysis of the β tubulin-bound GTP, which is buried at dimer-dimer 
interface and becomes nonexchangeable too. As a result, the microtubule body 
is made up of GDP-bound tubulin units, whereas, at the growing end, a layer of 
GTP-bound tubulins (the so-called GTP-cap) is present. A polymer made up of 
just GDP bound is unstable and would lead to the formation of curved 
protofilaments which eventually depolymerize [40]. The GTP-cap has a great 
importance in stabilizing a straight protofilament, thus promoting a regular 
microtubule growth. 
  
 
Figure 2 Microtubules polymerization occurs through α-β tubulin head-to-tail association. 
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Tubulin polymerization is characterized by a complex dynamics, with 
microtubules elongation or disruption taking place according to the cell needs. 
The alternation of microtubules growing and shrinking phases is called 
dynamic instability (Figure 3) [41]. According to such process, tubulin 
polymerization occurs through periodic slow growing phases as far as the GTP 
cap is present at the plus-end, followed by quick disruption stages (the so-
called catastrophes) when the GTP-cap is lost. The recovering of a growing 
phase is called rescue and takes place when the GTP-cap forms again at the 
plus-end.  
 
Figure 3 Microtubules dynamics is characterized by alternative growing and shrinking phases, 
depending on the presence of a GTP-cap at the plus-end. (adapted from  [42]) 
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Protofilament polymerization is made possible by a delay between the 
head-to-tail association and the GTP hydrolysis. In this way, during the 
growing phase, a GTP molecule can always be present at the plus-end  of the 
protofilaments, thus stabilizing the GDP-rich body and allowing the formation 
of straight microtubules. On the other hand, when the GTP cap is lost, 
protofilaments can’t grow in a straight conformation any longer and quickly 
disassemble.  
 
 
2.2 Microtubules biological role 
The high microtubules dynamicity is of fundamental importance for 
their biological role. In fact, being able to extend throughout the cytoplasm, 
they’re not only allowed to transport organelles and vesicles essential for a cell 
life, but, during mitosis, can also search and capture chromosomes to make the 
cell division possible (Figure 4) [43] [44]. Microtubules origin from cellular 
structures called centrosomes, which are composed of two units (the so-called 
centrioles) made up of tubulin filaments. In the early stage of mitosis (the 
prophase), the two centrioles of a single centrosome separate and each of them 
becomes the future centrosome of the daughter cell. A new network of 
microtubules (the so-called mitotic spindle) can thus grow from the newly 
generated organelles, extending throughout the cytoplasm. During the 
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metaphase, the centrosomes migrate to opposite sides of the cell, with the 
microtubules being able to scan the whole cytoplasm and capture the 
chromosomes, aligning them in the middle region of the cell. Once the 
chromosomes are all aligned, the migration of the chromatides toward the 
opposite pole of the cell takes place. Finally, during the telophase, the division 
into two daughter cells occurs, once the chromosomes are completely pulled to 
opposite parts of the mother cell.  
 
Figure 4 During mitosis, microtubules are responsible for the separation of the genetic material 
between the daughter cells. Being able to grow throughout the cytoplasm, microtubules can capture 
the chromosomes and attract them towards opposite poles in the mother cell. [45] 
 
The role of microtubules dynamics during mitosis is thus 
straightforward. Microtubules plus-end can grow freely in the cytoplasm 
(reaching a length of typically 5-10µm [46]) and allow the capture of the 
chromosomes [47], whereas the minus-end is anchored to the centrosomes. 
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Once a chromosome is bound to one microtubule, it then connects to another 
one coming from the opposite pole. The strain generated by the microtubules 
coming from the two poles forces the chromosomes to align along the cell 
equatorial plane. At that stage, microtubules depolymerization pulls the 
chromatides to opposite sides of the cell, so allowing the anaphase to take place. 
 
 
2.3 Microtubules as anticancer target 
It is thus clear that microtubules have a fundamental role in the division of 
the genetic material between the daughter cells. Therefore, tubulin and 
microtubules can  be seen as important targets in the development of anticancer 
agents [48] [46] [49]. In fact, by developing molecules able to target tubulin, one 
could interfere with the regular microtubules dynamics, so avoiding tumour 
cells duplication [50]. 
 Current chemotherapeutic agents targeting microtubules can be classified 
into two main categories [51] [52]: 
 
 microtubule destabilizing agents, inhibiting microtubules 
polymerization; 
 microtubule stabilizing agents, promoting microtubules 
polymerization. 
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The first class of molecules, which includes vinca alkaloids and 
colchicinoids, acts, at high concentrations, by blocking microtubules dynamics 
and thus mitosis, leading to cell death by apoptosis. The second class of 
molecules, which includes paclitaxel, on the other hand, acts by stabilizing the 
microtubules, so avoiding the transport of the chromosomes to the daughter 
cells. In both cases, the antimitotic action is due to the alteration of the correct 
microtubules dynamics, which inhibits the mitosis and avoid the correct 
distribution of the genetic material. 
The main drawback in the use of chemotherapeutics is that they 
obviously target every kind of cell, not only tumour ones. Although cancer cells 
are characterized by a higher replication rate, with respect to non-cancer cells, 
so that they’re more affected by the action of a chemotherapeutic, side effects 
usually occur [53] [54], such as the decrease in the production of blood cells by 
the bone marrow, the insurgence of ulcers or the reduction of the immune 
defences. Moreover, the effectiveness of such agents is made troublesome by 
the insurgence of mechanisms of resistance by tumour cells, linked to the 
alteration of the microtubules structure or the mutation of tubulin amino acidic 
sequence. 
Current antimitotic agents are found to target three different sites in 
microtubules structure (Figure 5): 
 the vinca domain, located at the interface between two tubulin dimers; 
 the taxol site, located on the β-tubulin surface; 
 the colchicine site, located at the interface between two monomers. 
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The vinca domain [55] [56] [57] is targeted by a great number of compounds 
having a proved antimitotic action, such as vinblastine, rhizoxin, spongistatin 
and dolastatin, that bind different regions of the large interdimer surface [58]. 
At the taxol site binds paclitaxel [59] [60], which has a widespread clinical use 
against ovarian, breast and lung cancer. Colchicine site is the target for 
colchicinoids [61] [62] [63], whose use as anticancer agents is nonetheless 
limited by the high number of side effects. 
 
 
 
 
 
Figure 5 Representation of a tubulin tetramer made up of adjoining α-β tubulin dimers. The site of 
actions of currently used antimitotic agents are highlighted (the vinca domain in red, the taxol site 
in orange and the colchicine site in yellow) 
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2.4  The role of vinblastine as antimitotic agent  
Vinblastine (Figure 6) [64] is a potent antitumor drug which has been 
used for a long time in the treatment of leukaemias, lymphomas, lung and 
breast cancers and was 
originally discovered in the 
extracts of leaves of the 
Catharanthus rosea (Vinca 
rosea) plant independently at 
the University of Western 
Ontario in 1958 [65] and at 
the Lilly Research 
Laboratories  [66]. 
Vinblastine belongs to the Vinca alkaloids class, so it inhibits the correct 
microtubules elongation by targeting tubulin [67] [68]. In particular, it is well 
known that vinblastine favours a curved tubulin protofilaments conformation 
[69]. Tubulin is thus not able to polymerize in a straight conformation anymore, 
but form spirals and rings [70] [71] [56] which cannot assemble to form 
microtubules correctly (Figure 7). As a consequence, microtubules biological 
action during mitosis is inhibited and tumour cells undergo apoptosis. In 
particular, cells that are blocked in mitosis exhibit a series of vinblastine 
concentration-dependent changes in microtubules and chromosomes 
organization [72] [49] [73], with vinblastine-induced abnormalities in 
Figure 6 Vinblastine chemical structure. 
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microtubules structure and dynamics becoming increasingly pronounced as 
vinblastine concentration raises.  
Vinblastine binding site has been elusive until the definition of its 
crystal structure in complex with tubulin [74]. The crystal structure shows that 
vinblastine is bound at the interface with two tubulin dimers associating 
longitudinally, in such a way to act as a wedge in between them, thus forcing 
the tetrameric structure to a bent conformation which differs from the straight 
one occurring when vinblastine is not present [75].  
In particular, it is interesting to observe that vinblastine binding pocket 
is composed of tubulin residues which are involved in the longitudinal 
interactions when the straight protofilament polymerizes, i.e. loop T7, helix H10 
and strand S9 in the α subunit and loops T5 and H6-H7 in the β subunit.  
 
 
 
Figure 7 Vinblastine induces a bending in the protofilament structure, resulting in the formation of 
tubulin spirals and rings [74]. 
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When vinblastine is bound at the interface, 80% of its surface area is 
buried between the two dimers, so forming a tight packing with α and β 
tubulin. A deeper understanding of the nature and energetics of the interactions 
between tubulin and vinblastine is essential to characterize the mechanism 
through which the bent tubulin conformation is stabilized, providing useful 
details for the development of new drugs with improved properties targeting 
the vinca site [76]. 
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3.1 Molecular dynamics simulations 
In order to get into more depth in the mechanism of stabilization of a 
curved tubulin protofilament by vinblastine, two molecular dynamics 
simulations were performed on two different systems. The first system taken 
into account consisted of two tubulin dimers interacting longitudinally to form 
a straight tetramer. The second system included a tubulin tetramer-vinblastine 
complex, which had thus a bent conformation, as mentioned above, due to the 
presence of vinblastine wedging at the interface between the two protein 
subunits ( 
Figure 8). The structures for the molecular dynamics simulations were 
obtained from the Protein Data Bank (PDB). Nonetheless, particular precautions 
had to be taken in order to get suitable starting points for the computational 
analysis, as explained in more details in the Materials and Methods box. 
Vinblastine mechanism 
of action 
Chapter 3 
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Once the linear and the bent tubulin tetramers were correctly set up, 
they both underwent a 5 ns molecular dynamics simulation in explicit water 
solvent and counterions. In order to validate the results of the molecular 
dynamics simulation, the Root Mean Square Deviation (RMSD) from the initial 
structures was calculated on α carbons (Figure 9). The plots clearly showed that 
both structures evolved to a stable conformation.  
 
 
3.2 Computational alanine scanning 
In order to investigate how the interaction between tubulin dimers 
changes in the straight or bent conformation, the attention was focused on the 
interfacial residues, which were identified in the linear structure as the ones 
showing a non-zero difference in the solvent accessible surface area (SASA), 
calculated with the software NACCESS [77], in the tetrameric vs. the dimeric 
unit. In other words, the per-residue SASA was calculated for the two single 
dimers and for the tetramer and interfacial residues were identified as those 
having a different value in the dimer and in the tetramer. A total of 176 
interfacial residues was identified in this way. [78] A computational alanine 
scanning was then performed on the identified interfacial residues, which 
allowed the classification of the amino acids according to the difference in the 
binding free energy (ΔΔG) upon mutation into alanine. 
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Figure 8 Vinblastine wedging at tubulin-tubulin interface stabilizes a bent tetramer conformation. 
 
 
Figure 9 RMSD calculated on α-carbons for the MD simulations of the bent and the linear tetramer. 
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Materials and methods 
The initial structure of the linear tetramer was obtained from the Protein Data Bank (PDB 
id 1TUB [78] corresponding to a structure of the pig tubulin α/β heterodimer determined in a 
polymerized state composed of antiparallel protofilaments forming a planar sheet, which results in 
a model particularly suitable for the study of the longitudinal interactions. The tetrameric system 
was built by adding to the crystal structure a second dimer with an 80 Å translation (according to 
crystallographic information) of the tubulin unit along the protofilament axis, which corresponds to 
the x-axis in the PDB file. 
Since no crystal structure of pig tubulin in its complex with vinblastine was available, the initial 
structure of the curved tubulin tetramer was obtained by superimposing the pig tubulin dimer 
corresponding to the 1TUB pdb file onto each of the two cow tubulin dimers in the 1Z2B pdb file 
[74] thus obtaining a pig tubulin tetramer which matched the overall bent topology of the 
vinblastine-bound tubulin. The vinblastine molecule was then manually docked in its natural 
binding pocket corresponding to the crystal structure position and the absence of overlapping 
atoms was verified, as well as the conservation of the contact found in the crystal structure. 
Molecular dynamics simulations were carried out with the AMBER 9 package [79] using 
explicit solvent and periodic boundary conditions. The 2003 force field [80] was used for the 
protein and the Generalized Amber Force Field (GAFF) [81] for the vinblastine molecule. Missing 
vinblastine parameters were calculated according to Wang et al. [82]. The system was solvated with 
TIP3P waters [83] and neutralized with sodium ions. The SHAKE algorithm [84] was employed to 
constrain all bonds involving hydrogen to their equilibrium bond lengths, which allowed an 
integration step of 1 fs. Both the linear and the curved tetramer were first submitted to 10000 steps 
of minimization (1000 steps using the steepest descent and 9000 using the conjugated gradient 
method). The systems were then equilibrated for 100 ps with the number of particles, system 
volume and temperature (300 K) constant (NVT conditions) in order to equilibrate the temperature 
of the system, and subsequently for 100 ps with number of particles, system pressure (1 atm) and 
temperature (300 K) constant (NPT conditions) in order to equilibrate the density of the system, 
with a 500 kcal mol−1 Å−2 restraint on the positions of backbone atoms. 
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 A 5 ns productive-phase molecular dynamics simulation at NPT conditions (1 atm, 300 K) of 
each system followed equilibration. Positional restraints on backbone atoms were not imposed in 
the productive phase. A 9 Å cutoff for non-bonded interactions was applied and Particle Mesh 
Ewald algorithm [85] was employed to calculate long-range electrostatic interactions. 
The length of the molecular dynamics run was adequate to sample the conformational 
variability of the protein surface and was consistent with the simulation time used by other authors 
in previous articles on tubulin [86] or on systems of comparable size [87]. Free energy of binding 
between tubulin dimers in the linear and bent tetramer, as well as that between vinblastine and 
tubulin was evaluated using the Molecular Mechanics Generalized Born Surface Area (MM-GBSA) 
approach [30]. The entropic contribution to binding free energy was evaluated with the NMODE 
module of the software package AMBER 9. Due to the huge dimension of the systems under 
consideration, only residues forming the contact surface between the two dimers were considered, 
adopting a strategy that proved to be viable and reliable in dealing with large systems [87]. 
Calculating the entropic contribution to vinblastine binding free energy, the vibrational entropy 
term was evaluated for the ligand and for the protein residues laying within a 8 Å radius from 
vinblastine, as suggested by Kuhn and Kollman [88]. The entropic contribution was evaluated on 50 
snapshots extracted from the last 2 ns of the simulation. The computational alanine scanning was 
carried out on snapshots taken at 10 ps intervals from the last 2 ns of the trajectories (200 snapshots 
in total). For each amino acid located at the interface, all side-chain atoms beyond Cβ were removed 
and the missing hydrogen was added, so obtaining the alanine sidechain. The ΔG of binding was 
calculated as described above both for the wild type and the mutated complex. In this instance it is 
not needed to calculate the entropic contribution, since it is considered to be the same in the two 
cases, thus cancelling out when computing the ΔΔG value [31]. A 150 nM physiological saline 
concentration was also used for the alanine scanning calculations. 
 
Residues showing a ΔΔG > 4 kcal/mol were considered to give the 
highest contribution to the binding between tubulin subunits and were labelled 
as hot-spots. Residues having ΔΔG between 2 kcal/mol and 4 kcal/mol or less 
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than 2 kcal/mol were labelled as warm-spots or cold-spots, respectively. 
Focusing on the linear tetramer, a numerous set of hot- and warm-spots was 
identified, clearly displaying that the binding energy is not evenly distributed 
at the surface, but is mostly concentrated on some key residues. In particular, it 
was observed, as it usually happens at protein-protein interfaces (see Chapter 
1), that such residues tended to be grouped in small clusters close to one 
another in the three-dimensional structure and often in the amino acidic 
sequence, so as to form ‚hot stretches‛ of residues of key importance for protein 
association. Hot- and warm-spots in the linear tetramer were found to be evenly 
distributed between the α and β subunit and were involved in a complex 
network of interactions involving salt-bridges, hydrophobic contacts and 
hydrogen bonds. 
Computational alanine scannings on both the linear and the bent 
structure were performed over the last 2ns of the MD simulations, once the 
systems reached equilibrium (Figure 9). As to the vinblastine-bound system, 
two separate sets of alanine scanning had to be performed, the first one 
including vinblastine as part of α tubulin and the second one considering 
vinblastine as part of the β subunit. This approach was necessary to monitor not 
only the change in the ΔΔG values upon vinblastine insertion at the interface, 
but also to highlight interactions of any of tubulin residues with vinblastine 
itself, taking into account the fact that the mutual interactions between residues 
belonging to the α and β tubulin subunit, respectively, may be replaced by 
interactions with the bound vinblastine wedged in between. So, if one includes 
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vinblastine as part of α tubulin, its interactions with β tubulin can emerge from 
the results, and the same happens the other way round. This can be better 
understood by getting into more depth into the results of the computational 
alanine scanning. 
 
 
 
 
 
 
 
 
 
 
Figure 10 Hot and warm spots 
distribution at the dimer–dimer 
interface. Different colors, from green 
to red, refer to the variation in the 
binding energy of the complex on 
mutation of each of the hot and warm 
spots identified. The α and β subunits 
contacting surfaces are represented for 
the linear tetramer (a, b), and for the 
bent tetramer (c–f). Analyzing the bent 
tetramer, two distinct alanine 
scanning calculations were performed, 
considering vinblastine either as part 
of the α (c, d) or of the β subunit (e, f). 
Vinblastine is colored in purple on the 
subunit to which it belongs, and 
shaded on the opposite one. 
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At a first glance, the comparison between the results obtained for the 
straight and the bent tetramer showed a general reduction in the ΔΔG values 
upon vinblastine binding, as it would be expected given the conformational 
change induced in the tetrameric structure (Figure 10). The analysis performed 
on the straight structure led to the identification of 22 hot- or warm-spots. On 
the other hand, the number decreased to 15 or 17 in the bent conformation, 
depending on which subunit vinblastine belongs to. In particular, interfacial 
residues in the vinblastine-bound system were found to exhibit different 
behaviours of the ΔΔG values. 
A group of residues showed a reduction of their ΔΔG values greater 
than 40% with respect to the straight tetramer, regardless of the subunit 
vinblastine was included in (Figure 11a). In this case, the reduction is due to the 
perturbative action of vinblastine wedging at the interface, weakening the 
Figure 11 ΔΔG values obtained from alanine scanning for the linear tetramer (black bars), and the 
bent tetramer, considering vinblastine either as part of the α subunit (pale grey) or the β subunit 
(dark grey). In panel a, residues exhibiting ΔΔG reduction greater than 40% were grouped. In panel 
b, residues with smaller ΔΔG reductions are shown. Panel c gathers those residues in the vinca site 
exhibiting a strong dependence of ΔΔG on the subunit in which vinblastine was included during 
the calculation. 
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interactions that interfacial residues could establish in the linear conformation. 
This can be observed taking into account the most prominent hot-spots found in 
the vinblastine-free system Lys352 and Asp177’ (residues on the β subunit at 
the protein-protein interface are labeled with a prime on their sequence 
number), which took part in a strong salt bridge and were characterized by the 
highest ΔΔG values (19.9 and 17.43 kcal/mol, respectively). Lys352 was also 
involved in a second salt bridge (Figure 12) with the γ-phosphate of the GTP 
molecule bound to the facing β tubulin subunit, whereas Asp177’ established 
also a hydrogen bond with the Asn258 side chain. The binding of vinblastine at 
the interface led to a rearrangement of these residues and, as a consequence, the 
salt bridge between Lys352 and Asp177’ got weakened, with the average 
distance between the lysine amine nitrogen ant the aspartate carboxylic carbon 
increasing from 3.79 ± 0.17 Å in the linear system simulation to 4.06 ± 0.65 Å in 
the bent system one. The interaction of Lys352 with GTP was also affected, with 
the distance between the lysine amine nitrogen and the GTP γ-phosphorus 
raising from 3.52 ± 0.15 Å to 7.36 ± 1.0 Å. The hydrogen bond between Asp177’ 
and Asn258 was even no longer detected in the vinblastine bound complex. It is 
interesting to notice that Lys352 and Asp177’ are located at the edge of 
vinblastine binding site, so a dramatic effect is stressed when vinblastine is 
bound at the interface. 
Vinblastine can also affect indirectly the interactions between facing 
residues, as can be seen taking into account the behaviour of Arg2, which had 
its interactions weakened though located 15 Å apart vinblastine binding site 
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(Figure 12). In this case, Glu69’ was involved in electrostatic interactions with 
Arg2 and the amine charged group of Met1 in the linear tetramer. In the 
vinblastine-bound system, the bending of the structure caused a rearrangement 
of the N-terminus resulting in a reduction of Arg2 burial, with its solvent 
accessible surface area rising from an average of 15 ± 4 Å2 in the linear tetramer 
to 62 ± 10 Å2 in the  bent one, together with a departure of Met1 from Glu69’. As 
are result, ΔΔG values for these residues are indirectly lowered by vinblastine 
binding at the interface.  
 
 
Figure 12  Details of the network of interactions between tubulin dimers in the linear (a, c) and bent 
(b, d) tetramer are shown. Key salt bridges and hydrogen bonds that are preserved or lost upon 
vinblastine binding are highlighted. 
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Another group of amino acids wasn’t so much affected by the 
perturbating action of vinblastine and underwent only small changes in their 
ΔΔG values with respect to the straight tetramer (Figure 11b). This happened 
mainly for those residues located at the C-terminal of β tubulin, which are 
located far from vinblastine binding site and whose structure in the linear and 
the bent tetramer is superimposable [89]. In fact, this region is the hinge around 
which dimers rotate to reach the bent conformation from the linear one.  
These residues thus are able to keep the interactions with the facing subunit, 
although vinblastine is inserted in between and their ΔΔG values are only 
slightly changed. 
The most interesting behaviour was exhibited by three residues 
belonging to vinblastine binding site, Leu248 on the α subunit and Tyr208’ and 
Tyr222’ on the β subunit (Figure 11c). In these case, the ΔΔG resulted to be very 
different depending on the subunit in which vinblastine was included for the 
computational alanine scanning. In particular, Leu248, belonging to the α 
subunit, showed a ΔΔG value of 3.43 kcal/mol in the straight conformation, 
turning to zero when vinblastine was considered as part of the α subunit itself, 
but, on the other hand, slightly increased to 4.46 kcal/mol when vinblastine was 
considered as part of the β subunit. One can thus infer that in this case it is 
vinblastine itself which act as an interacting counterpart of Leu248 and such 
interaction can be detected only when vinblastine is considered as part of the 
facing subunit. For the same reason, Tyr208’ and Tyr222’ conserved their ΔΔG 
values when vinblastine was considered as part of the opposite α subunit. 
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Therefore, in the bent conformation, these three residues did not interact 
anymore with the facing tubulin residues, but with vinblastine, which thus 
acted by crosslinking the interactions between α and β subunits. Getting into 
more detail, Tyr222’ was involved in hydrophobic contacts with Leu248 and 
Pro325, whereas Tyr208’ established hydrophobic interactions with Lys326, 
Pro325 and Asp329. On the other hand, in the bent structure Tyr208’ and 
Tyr222’ turned to interact with vinblastine catharantine domain, whereas 
Leu248 established hydrophobic contacts with both the catharantine and the 
vindoline domain (Figure 13). 
 
 
Figure 13  Detail of the hydrophobic interactions contacts established by vinblastine (represented 
in Van der Waals spheres) with Leu248 on α tubulin and Tyr208’ and Tyr 222’ on β tubulin. 
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The analyses showed that, although potential hydrogen bond donors 
and acceptors were present, the interactions stabilizing the tubulin-vinblastine 
complex were essentially hydrophobic. 
The observed vinblastine crosslinking behaviour allowed an 
explanation for the stabilization of a tubulin bent conformation: whereas the 
disruption of a number of key interactions for tubulin self-association was 
induced by vinblastine, on the other hand the molecule itself introduced new 
interactions with both α and β subunits, acting as a glue between them. As a 
consequence, the tetramer is obviously forced to a curved conformation, with a 
~18° angle between the dimers observed throughout the simulation, in 
agreement with the value of the crystal structure. The conformational change 
also led to an increase of the distance between the centres of mass of the 
interacting tubulin dimers, which turned from 80.49 ± 0.23 Å in the linear 
tetramer to 82.66 ± 0.48 Å in the bent one. 
 
 
3.3 Free energy change calculations 
Computational alanine scanning only provided and evaluation of the 
role of the single amino acids in vinblastine stabilizing action. In order to 
investigate the compensation of energy loss due to the bending upon 
vinblastine insertion at dimers interface, the free energy change as a whole from 
Part I – Atomic-level analysis of vinblastine mechanism of action 
 
 
 
38 
 
the linear to the bent conformation needed to be calculated. Due to the large 
dimensions of the system, a molecular dynamics simulation of the bending 
process was impossible to perform. It was thus necessary to decompose the 
process into elementary reactions whose ΔG could be more easily estimated 
computationally. For this purpose, the thermodynamic cycle showed in Figure 
14 was used, so that it was necessary to calculate the binding free  energy 
between two dimers forming the linear tetramer (ΔG3), the binding free energy 
between two dimers in the presence of vinblastine to form the bent tetramer 
(ΔG4) and the binding free energy of vinblastine bound to only one tubulin 
dimer (ΔG2). Also in this case, as it was necessary to do for the computational 
alanine scanning, vinblastine had to be considered as part of either α or β 
subunit for the calculation of ΔG2 and ΔG4. As a result, two values for the free 
energy of addition of vinblastine to a linear tetramer to get the bent structure 
(ΔG1) were obtained.  
 
Figure 14 Thermodynamic cycle used to calculate the free energy change as a whole from the linear 
to the curved tetramer. 
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The entropic contribution was also taken into account for the binding 
free energy calculations. Nonetheless, due to the large size of the system 
introducing memory and CPU limits, it was not possible to evaluate it 
considering the whole complex, but it was calculated only on a subset of it, as 
explained in the Materials and methods box. The calculations led to a value of 
binding free energy of -16.51 kcal/mol (with a standard error of  3.18 kcal/mol) 
when vinblastine was considered as part of the α subunit and of -11.39 kcal/mol 
(with a standard error of 3.19 kcal/mol) when vinblastine was included in the β 
subunit. The results thus showed that the formation of the bent tetramer is 
favoured in the presence of vinblastine wedging between tubulin subunits and 
that vinblastine binding free energy actually compensates the energy loss 
following the tetramer bending. It is clearly deductible that the association of 
tubulin dimers is still possible in the presence of vinblastine, although the 
formation of curved protofilaments (and not straight) is favoured, resulting in 
an incorrect microtubules formation and the subsequent inhibition of tubulin 
biological activity.  
 
 
3.4 Vinblastine effect over GTP hydrolysis 
A further aspect which is worth noticing, is the influence of vinblastine 
on the hydrolysis of the tubulin-bound GTP, whose rate is experimentally 
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observed to decrease [90]. Comparing the MD simulation of the bent and the 
linear tetramer, it was possible to highlight a change in the positioning of the α 
tubulin H8 helix [91] [92], which includes the residue Glu254 that was proven to 
play a fundamental role in the GTP hydrolysis [93]. In fact, an increase of the 
distance between Glu254 and the GTP γ-phosphate was observed, with its 
value raising from 3.54 ± 0.26 Å in the linear tetramer to 5.24 ± 0.63 Å in the 
vinblastine-bound one. As a result, water molecules were allowed to slip into 
the gap between Glu254 and GTP, so disrupting the correct residues orientation 
for nucleotide hydrolysis.  
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The changes in the network of interactions at the protein-protein 
interface induced by vinblastine binding to tubulin were explored through a 
computational approach comprising molecular dynamics simulations and 
computational alanine scannings. The analyses allowed the identification of the 
key residues involved in the interactions between tubulin and vinblastine, 
pointing out that the molecule effectively acts by crosslinking the interactions 
between the dimers. As a matter of fact, vinblastine, although binding at the 
interface between tubulin subunits, does not screen the interdimer interactions, 
but, on the contrary, bridges them, thus leading to the stabilization of a curved 
tubulin–vinblastine complex. Moreover, the structural changes induced by 
vinblastine are consistent with the decrease of the rate of GTP hydrolysis 
observed experimentally. The stabilization of a curved tetramer conformation 
can be seen as the first step of the formation of bent tubulin polymers, which is 
the primary cause of microtubules disassembly. The deep insight into the 
nature of the interactions between vinblastine and tubulin achieved could be 
valuable in the better understanding of vinblastine mechanism of action to 
contribute to the development of new antimitotic agents targeting the vinca site.  
Conclusions 
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4.1 FtsZ role in bacterial cells  
In prokaryotes, such as bacteria, cell division occurs through a protein 
homologue to tubulin known as FtsZ [94]. Like tubulin, FtsZ polymerizes in a 
GTP-dependent way [95] [96] to form a circular structure called z-ring [97], 
whose contraction during the division process allows the septation and the 
separation of daughter cells (Figure 15) [98]. Nonetheless, details about how z-
rings assemble and exert their action during cell division are still not clear. 
What is known is that, in vivo, GTP binding to FtsZ promotes a head-to-tail 
protein association to form linear protofilaments, like in microtubules assembly 
[99]. Protofilaments later on establish lateral interactions to form protein 
suprastructures constituting the z-ring [100] [101], but nothing is known yet 
Chapter 4 
FtsZ and z-rings  
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about its set-up, i.e. whether it’s made up of single protofilaments, bundle or 
helices.  
Nonetheless, recent analyses showed that FtsZ polymers, unlike 
microtubules, are mainly constituted by GTP-bound monomers, whereas 
nucleotide hydrolysis upon FtsZ self-association has a destabilizing effect [102].  
 Figure 15 Z-rings are FtsZ polymers whose contraction has a key role in bacterial cells duplication. 
 
FtsZ is thus allowed to polymerize until GTP is present inside the 
cytoplasm, allowing a continuous nucleotide exchange with hydrolysed FtsZ-
bound GTP, whereas protofilaments disassemble when GTP is not available 
anymore [103]. The main explanation for this dynamics, which is 
complementary to microtubules’ one, is that GTPase reaction kinetics are 
different for tubulin and FtsZ. In microtubules, GTP hydrolysis occurs very 
quickly upon tubulin self-association, but the nucleotide binding site is buried 
at protein interface, thus avoiding nucleotide exchange [104]. Therefore, 
microtubules are mostly made up of GDP-bound tubulins. On the other hand, 
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 the rate-limiting step for FtsZ polymerization is GTP hydrolysis, since the 
nucleotide binding site has an opening to the solvent of approximately 8 x 9 Å 
[105], which allows the GTP to diffuse freely right after its hydrolysis and 
nucleotide exchange can rapidly occur.  
 
 
4.2 FtsZ homology to tubulin 
Tubulin and FtsZ have a high structural 
homology [106] [107] (Figure 16). The cores 
of the two proteins are in fact structurally 
identical, whereas discrepancies occur at 
the C-terminal (which is composed of a pair 
of long helices for tubulin and of a small β-
hairpin for FtsZ) and the N-terminal section 
(where FtsZ has an extra helix). The 
similarity between the two proteins is 
confirmed by the low RMSD value (4.3 Å) 
calculated over the α-carbon atoms within 
the common core residues [108].  
 Figure 16 FtsZ has a high structural 
homology to tubulin. 
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Figure 17 Sequence alignment between tubulin and FtsZ shows a matching only in biologically 
relevant regions. 
 
Despite the high structural homology, the structure-based sequence 
alignment shows a weak sequence match (Figure 17). The regions of highest 
homology correspond to residues involved in nucleotide binding site (loops T1, 
T2, T3, T4, T6). A further region of common residues corresponds to the T7 
loop, which is involved in the longitudinal association in tubulin 
polymerization, thus leading to the assumption that FtsZ polymerizes in a 
similar way [109]. Mutagenesis studies of E.coli FtsZ showed that T7 loop is also 
important for GTPase activity, indicating that GTP hydrolysis involves residues 
from two different subunits and can occur only when they come into vicinity as 
the head-to-tail associations takes place [110]. 
Regarding the lateral interactions, as already pointed out, only few 
information is known. Nonetheless, in 2004, Leung and colleagues were able to 
crystallize Mycobacterium Tuberculosis FtsZ arranged in a laterally oriented 
Part II – Design of peptides inhibiting FtsZ polymerization 
 
49 
 
 
 dimer showing remarkable differences with respect to tubulin lateral 
interactions [111]. 
 
 
Figure 18 Structure of two FtsZ monomers interacting laterally. 
 
To achieve such dimer conformation, subunit A in Figure 18 has to 
undergo unexpected secondary structure rearrangements to establish the 
proper lateral interactions [112]. In fact, whereas helix H2 adopts the expected 
α-helix conformation in subunit A, it extends to a β-strand conformation in 
subunit B. Moreover, it shows that loop T3 is fully ordered around GTP when 
it’s bound to subunit A, whereas the loop becomes disordered in the absence of 
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the nucleotide in subunit B [113]. Similarly, 
loop T4 is wrapped around the nucleotide in 
the GTP-bound FtsZ, but collapses inside the 
empty active site when nucleotide is not 
present. It was found that GTP binding is 
closely linked to the switching between the 
α-helical and the β-strand conformation of 
H2. In fact, the only way for H2 to avoid an 
overlap with the ordered T3 loop is to adopt 
an α-helix conformation. On the other hand, 
when the nucleotide is not bound and the T3 
loop can open, H2 is free to protrude towards 
the nucleotide binding site and extend in a β-
strand conformation. All these 
rearrangements make the lateral dimer 
conformation possible and allow the proper 
orienting of interfacial residues for binding. 
Mutagenesis studies pointed out that the 
formation of such lateral dimers has an 
important relevance in the biological activity 
of the FtsZ. In fact, the mutation of the 
residues Asp84 and Asp94, which are located at the lateral interface, destabilize 
FtsZ polymerization or even prevent z-ring assembly [114]. Nonetheless, 
Figure 19 Hypothetical z-ring helical 
structure based on known FtsZ 
structural data. 
Part II – Design of peptides inhibiting FtsZ polymerization 
 
51 
 
 
 although the physiological relevancy of such lateral contacts is clear, it is not 
yet known how the longitudinal polymerization combines with lateral FtsZ 
association to give rise to those suprastructures the z-ring is made up of. Based 
on the evidence that FtsZ can assemble in spiral filaments, as seen by electron 
microscopy assays [115], a possible spiral assembly model can be built using the 
lateral dimer as a base [111] (Figure 19).  
 
 
4.3 FtsZ as innovative target in drug design 
Given its importance in bacteria replication, FtsZ is gaining an ever-
growing attention in the development of antibiotic agents, since the alteration 
of the regular FtsZ assembly could eventually prevent bacterial cells replication, 
similarly to what happens for antimitotic agents and tubulin [116] [117] [118]. 
The discovery of a new class of antibiotic agents has nowadays an important 
relevance in the medical field. In fact, since the discovery of penicillin in the 
first decades of the XX century, bacteria developed in the last years an ever 
growing resistance to commonly used antibiotics [119] [120]. This was initially 
due to a misuse and overuse of antibiotics in hospitalized patients, leading to 
the appearance of resistant bacteria which later on spread to the community, 
causing severe illnesses in previously non-vulnerable patients.  
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Figure 20 Currently used antibiotics target a large number of sites in bacterial cells [121]. 
 
Resistance to antibiotics occurs through mutations of bacteria 
themselves, which are thus becoming not targetable anymore by the same 
agents that were originally active. Current antimicrobials can be classified in 17 
classes [121] acting against a wide range of targets, i.e. inhibiting cell-wall 
synthesis or DNA replication, so the way bacteria respond is different for each 
case (Figure 20). In order to overcome resistance, antibiotics have been 
modified in order to preserve their action. Nonetheless, the discovery of new 
targets would provide a significant improvement, due to the difficulty in 
developing active modified agents. Targeting FtsZ could thus be a valuable 
strategy in the discovery of a new class of effective antimicrobials with low 
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 resistance issues. In fact, interfering with FtsZ self-assembly is an eligible way 
to stop bacterial proliferation [122]. Numerous small molecules targeting FtsZ 
have been described so far, mainly derived from natural sources and identified 
by high throughput screening. A few peptidic inhibitors have also been studied, 
i.e. the antimicrobial peptides Edeine B1 [123] and MCiZ [124], as well as 
stathmine-derived peptide [117].    
 
 
4.4 A new strategy in drug design 
A viable approach towards the alteration of z-ring formation is to 
interfere with protein-protein interactions responsible for FtsZ self association. 
The design of molecules targeting protein-protein interactions, albeit proven to 
be a very complex task, due to the peculiar features of protein interfaces and 
their inherent variability (see Chapter 1), has lately gained an increasing interest 
as a therapeutic strategy and is presently one of the main goals of medicinal 
chemistry [125]. As already mentioned, in general only a minor part of the 
residues at protein-protein interfaces actually contribute to the binding energy. 
Therefore, molecules inhibiting protein-protein association should be targeted 
to those particular ‚hot-regions‛ critical for proteins binding. In the case of 
FtsZ, an in-depth analysis of the network of interactions between single 
monomers (known the dimer structure described above) would lead to a 
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thorough understanding of how the subunits associate and can thus give a hint 
about where inhibiting agents should bind. Similarly to the approach used in 
the Part I to analyse the tubulin system, in the present part a computational 
alanine scanning can thus be performed over the interfacial FtsZ residues, so 
identifying those contributing significantly to the binding energy (i.e. warm- 
and hot-spots). If a potential binding epitope is found, and if it is made up by 
residues that are next to one another not only in the topology but also in the 
amino acidic sequence of the protein, then a set of peptides can be synthesised 
to match the identified motif (Figure 21). Such peptides could therefore 
competitively inhibit FtsZ polymerisation by selectively binding to protein sites 
critical for the self-assembly process. A similar approach was used in a recent 
paper by Pieraccini et al. [86] on the inhibition of tubulin-tubulin interactions, 
providing reliable results and leading to the design of effective antimitotic 
peptides [126] [127]. 
 
  
Figure 21 Schematic representation of the approach used. The computational analysis of the 
protein-protein interface (panel a) can lead to the identification of a set of contiguous hot-spots 
(panel b). By cutting out the set of hot-spots from the mother subunit, one could obtain a small 
peptide able to inhibit protein-protein association. 
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5.1 Molecular dynamics simulation 
As a starting point for the analysis of the interactions between FtsZ 
monomers, the structure of the dimer obtained crystallographically by Leung 
and colleagues was taken into account. Nonetheless, it was necessary to 
improve it so to make it suitable for a molecular dynamics simulation (see 
Materials and Methods box). Once an optimal starting structure was obtained, 
the FtsZ dimer underwent a 5 ns molecular dynamics simulation. As it 
happened in the case of the tubulin systems, the complex reached equilibrium 
during the simulation, as it can be pointed out by evaluating the RMSD plot 
calculated on the α-carbons (Figure 22). The binding free energy between FtsZ 
monomers was also calculated throughout the simulation, resulting in an 
average ΔG value of -41.75 ± 5.70 kcal/mol (Figure 23). 
Chapter 5 
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Materials and methods 
The initial structure of the FtsZ dimer was obtained from the Protein Data Bank (PDB id 
1RLU [111]). Nonetheless, the lack of some residues in the crystal structure, which couldn’t be 
detected experimentally, made it in principle impossible to perform a molecular dynamics 
simulation of the system. Whereas PDB’s chain A didn’t have missing residues, chain B lacked 
residues from Arg60 to Gly69 and from Gly170 to Ala173. In particular, residues from Arg60’ to 
Gly69’ corresponded to loop T3, which, as mentioned in Chapter 4, is disordered and thus not 
detectable on the subunit B, whereas it is fully ordered around GTP molecule on the subunit A. The 
missing loops where refined using the software MODELLER 9.6 [128]. The stereochemical quality of 
the resulting structure was checked using the PROCHECK software [129]. Molecular dynamics 
simulations were carried out with the AMBER 9 package [79] (2003 force field [80]),  using 
explicit solvent and periodic boundary conditions. The system was solvated with TIP3P waters [83] 
and neutralized with sodium ions. The SHAKE algorithm [84] was employed to constrain all bonds 
involving hydrogen to their equilibrium bond lengths, which allowed an integration step of 1 fs. 
The dimer was first submitted to 10000 steps of minimization (1000 steps using the steepest descent 
and 9000 using the conjugated gradient method). The system was then equilibrated for 100 ps with 
the number of particles, system volume and temperature (300 K) constant (NVT conditions) in order 
to equilibrate the temperature of the system, and subsequently for 100 ps with number of particles, 
system pressure (1 atm) and temperature (300 K) constant (NPT conditions) in order to equilibrate 
the density of the system, with a 500 kcal mol−1 Å−2 restraint on the positions of backbone atoms. A 5 
ns productive-phase molecular dynamics simulation at NPT conditions (1 atm, 300 K) of each 
system followed equilibration. Positional restraints on backbone atoms were not imposed in the 
productive phase. A 9 Å cutoff for non-bonded interactions was applied and Particle Mesh Ewald 
algorithm [85] was employed to calculate long-range electrostatic interactions. The free energy of 
binding between the subunits was evaluated using the Molecular Mechanics Generalized Born 
Surface Area (MM-GBSA) approach [30]. Computational alanine scanning was carried out on 
snapshots taken at 10 ps intervals from the last 2 ns of the trajectories (200 snapshots in total) using 
a 150 nM physiological saline concentration. 
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Figure 22 RMSD calculated on α-carbons throughout the simulation of the FtsZ dimer. 
 
 
 
Figure 23 Plot of the binding free energy between FtsZ monomers throughout the simulation. 
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5.2 Computational alanine scanning 
In order to get into more depth in the network of interactions stabilizing 
the FtsZ dimer and to understand on which residues the free energy of binding 
is concentrated, a computational alanine scanning was performed on the 
interfacial amino acids. As in the analysis of the tubulin complexes, the residues 
were identified as those showing a non-zero difference in the solvent accessible 
surface area in the dimeric vs. the monomeric unit using the software 
NACCESS [77]. In total, 71 interfacial residues were identified. A computational 
alanine scanning (Figure 24) was then performed on every interfacial amino 
acid, taking into account only a subset of snapshots extracted from the last 2 ns 
of the simulation, once the system reached equilibrium.  
As in the case of tubulin, the results pointed out that the binding energy 
is concentrated only on a subset of residues, classified as cold-spots (ΔΔG < 1 
kcal/mol), warm-spots (1 kcal/mol < ΔΔG < 2 kcal/mol) and hot-spots (ΔΔG > 2 
kcal/mol). On the whole, 10 hot-spots and 6 warm-spots were detected at the 
interface (Table 1). Residues belonging to subunit A are labelled with a prime. 
Arg60’ and Asp57 were found to be the most prominent hot-spots, with a ΔΔG 
value of 16.63 ± 1.92 kcal/mol and 11.76 ± 1.98 kcal/mol, respectively, with the 
two residues establishing a strong salt bridge. Nonetheless, Arg60’ and Asp57 
were isolated hot-spots, since no other warm- or hot-spots were identified in 
their vicinity, so making them not interesting for the purpose of our research, 
i.e. the identification of ‚hot-stretches‛ to be used as a starting point for the 
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 design of peptides able to bind FtsZ at the intermonomer region. Therefore, 
the attention was focused on the identification of clusters of contiguous warm- 
or hot-spots. Three groups, whose location at the interface is shown in Figure 25 
were detected: 
 
 Group 1 on subunit B, from Ser175 to Ser182; 
 Group 2 on subunit B, from Gln45 to Ser50; 
 Group 3 on subunit A, from Glu88’ to Met95’. 
 
Table 1 Warm- and hot-spots detected at the FtsZ dimer interface. In the last column, the group 
they belong to is shown. 
Residue ΔΔG value (kcal/mol) Group 
Leu56’ 2.78 ± 0.62  
Arg60’ 16.63 ± 1.92  
Leu89’ 2.13 ± 0.57 3 
Arg91’ 10.33 ± 1.97 3 
Asp94’ 1.20 ± 2.68 3 
Lys120’ 2.51 ± 1.68  
Leu122’ 1.30 ± 3.37  
Leu47 1.68 ± 0.38 2 
Leu48 3.89 ± 0.60 2 
Met49 3.61 ± 0.95 2 
Asp57 11.76 ± 1.98 2 
Glu102 4.44 ± 1.68  
Arg139 1.20 ± 0.62  
Met177 1.86 ± 1.19 1 
Phe180 4.13 ± 0.73 1 
Arg181 1.76 ± 2.56 1 
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Figure 25 Representation of the simulated dimer. The ‚hot-stretches‛ identified by computational 
alanine scanning are highlighted in red (Group 1), blue (Group 2) and green (Group 3) 
Figure 26 Detail of Group 1 residues at the FtsZ interface. 
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Taking into accout the Group 1, the main contributions to the binding 
are given by the hydrophobic interactions established by Phe180, with a ΔΔG of 
4.13 ± 0.76 kcal/mol, and Met177, with a ΔΔG of 1.86 ± 1.19 kcal/mol. Arg181 is 
involved in a salt bridge with Asp94’, although, as shown in Figure 26, arginine 
is also free to orient towards subunit B itself and interact with Asp178, so 
reducing its contribution to the binding with the facing protein. 
As to the Group 2, the binding to subunit B is ensured by a stable 
hydrophobic cluster composed by Leu47, Leu48 and Met49, whose ΔΔG values 
are 1.68 ± 0.38 kcal/mol, 3.90 ± 0.59 kcal/mol and 6.61 ± 0.95 kcal/mol, 
respectively. 
In the Group 3 (Figure 28), the most prominent hot-spot was Arg91’, 
with a ΔΔG value of 10.33 ± 1.97 kcal/mol, establishing strong salt bridges with 
Glu102 and Glu136 with the facing subunit B. The binding is further stabilized 
by a hydrophobic contact established by Leu89’, with a ΔΔG of  2.12 ± 0.56 
kcal/mol. Asp94’, as already mentioned, estabishes a weak salt bridge with 
Arg181 belonging to Group 1, so its ΔΔG of 1.20 ± 2.68 kcal/mol is 
charactherized by a high standard deviation. 
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Figure 27 Detail of the interaction established by residues belonging to Group2. 
. 
 
Figure 28 Close-up of the Group 3 residues at FtsZ interface. 
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As already mentioned, the aim of the work was the design of peptides 
able to bind FtsZ at the interface between monomers, in order to inhibit its 
biological activity. The ‚hot-stretches‛ found by computational alanine 
scanning could be used for this purpose, known their importance in FtsZ self-
association. In fact, by cutting them out of the mother subunit, one could obtain, 
in principle, peptides able to retain their binding capability to the facing 
protein. Nonetheless, the extraction of the peptides from their native protein 
environment could affect their binding ability, due to possible structural 
rearrangements.  
Therefore, three peptides were obtained from the three groups 
identified (Peptide 1, Peptide 2 and Peptide 3, according to the respective group 
names) and each of them underwent a further molecular dynamics simulation 
Chapter 6 
Design of peptides  
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in complex with the partner FtsZ subunit, in order to verify that they could still 
retain a good binding even when extracted from the mother protein. Peptides’ 
termini were capped with acetyl and amine groups (at N-terminal and C-
terminal, respectively), in order to avoid that their charged zwitterionic form 
could perturb their structure.  
 
 
6.1 Peptide 1 
Peptide 1 was obtained from the Group 1 located on subunit B, ranging 
from Ser175 to Ser182, and was simulated for 5 ns in complex with subunit A. 
Peptide 1 was characterized by a helical secondary structure, which was 
preserved throughout the whole dynamics (Figure 29) and which had a 
significant relevance in view of possible further optimizations for the 
development of non-peptidic mimetics [130] [131] [132].  
 
Figure 29 Starting and final snapshots extracted from the simulation of Peptide 1 in complex with 
FtsZ. 
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 As a consequence, the RMSD calculated on peptide’s α-carbons ( 
Figure 30) did not show noteworthy rearrangements of its secondary 
structure throughout the simulation.  
 
 
Figure 30 RMSD calculated on Peptide 1 α-carbons during its simulation in complex with FtsZ. 
 
Also the binding with the facing FtsZ subunit is preserved for the 
whole dynamics, as can be observed by calculating the binding free energy 
between Peptide 1 and FtsZ through time. As can be observed plotting the 
binding free energy vs. time (Figure 31), the peptide retained its association 
with the facing protein subunit, even when extracted from its mother protein, 
with an average ΔG value of  -18.06 ± 2.90 kcal/mol.  
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Figure 31 Plot of the ΔG between Peptide 1 and FtsZ throughout the simulation. 
 
A computational alanine scanning was then performed on the peptide 
residues, in order to evaluate how the results changed with respect to the same 
amino acids in the dimer (Figure 32). It resulted that the ΔΔG values were  
mostly preserved in the peptide (so confirming that the peptide actually 
retained its binding capability), with a noticeable increase for the Arg181 value, 
which turned from 1.76 ± 2.56 kcal/mol in the dimer to 6.50 ± 1.83 kcal/mol in 
the peptide. The reason is that arginine, when at the monomer-monomer 
interface, predominantly orients its side chain towards the subunit B it belongs 
to (as already seen in Figure 26). On the other hand, when the peptide is 
extracted from the protein, arginine turns to orient more favourably towards 
the facing subunit, so establishing a strong salt bridge with Asp94’. Besides the 
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 electrostatic interaction due to arginine, the association between Peptide 1 and 
FtsZ is also ensured by hydrophobic interactions established by Met177 and 
Phe180, which preserve their relevance for binding. 
 
 
Figure 32 Results of the computational alanine scanning for the Peptide 1. 
 
 
6.2 Peptide 2 
Peptide 2 was obtained from the hot-stretch ranging from Gln45 to 
Ser50 and was simulated for 5 ns in complex with subunit A. Also in this case, 
the peptide did not undergo evident structural changes, with respect to the 
starting structure obtained from the dimer (Figure 33), although it slightly shifts 
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over the protein surface throughout the simulation. The preservation of the 
original peptide structure was confirmed by the results of the RMSD calculated 
on α-carbons throughout the simulation (Figure 34).  
 
 
Figure 33 Starting and final snapshots of the simulation of Peptide 2  in complex with FtsZ. 
 
 
Figure 34 RMSD calculated on Peptide 2 α-carbons throughout the simulation. 
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 Also the free energy of binding was essentially stable during the 
simulation (Figure 35), with an average value of -35.45 ± 5.44 kcal/mol.  
 
Figure 35 Plot of the binding free energy vs. time calculated for the complex Peptide 2 - FtsZ. 
 
 
Figure 36 Results of the computational alanine scanning for Peptide 2. 
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As it happened for Peptide 1, the comparison of the computational 
alanine scanning with the results obtained in the dimer didn’t show particular 
differences, with ΔΔG values being preserved in the peptide (Figure 36). The 
biggest discrepancy is related to the residue Met49, whose ΔΔG decreased from 
3.61 ± 0.95 kcal/mol to 2.30 ± 1.12 kcal/mol. In this case, Met49 was involved 
both in a hydrophobic contact with Lys55’ through its side chain, both in a 
hydrogen bond with Lys55’ itself through its backbone. Both oxygen and 
nitrogen atoms belonging to Met49 are involved in stable hydrogen bonds with 
nitrogen and oxygen, respectively, belonging to Lys55’ backbone. In the 
peptide, the hydrophobic interaction is weakened, so leading to the observed 
decrease in the ΔΔG value. The hydrogen bonds are instead preserved, though 
it does not contribute to the alanine scanning result, which only takes into 
account side chain interactions. The other main interactions between Peptide 2 
and FtsZ include hydrophobic contacts between the two leucines and the side 
chains of the residues Leu56’ and Asp57’, as well as a weak salt bridge between 
Gln45 and Asn81’. Leu47 is also involved in a double hydrogen bond through 
its oxygen and nitrogen backbone atoms, as it happened for Met349, with the 
backbone of Asp57’. Also in this case, this interaction couldn’t be detected by 
the computational alanine scanning, although it greatly contributes to the 
association between the peptide and the protein. 
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 6.3 Peptide 3 
Peptide 3 was designed starting from the hot-stretch ranging from 
Glu88’ to Met95’ and was simulated for 5 ns in complex with subunit B. Unlike 
Peptide 1 and Peptide 2, a qualitative analysis of the trajectory clearly showed 
that Peptide 3 underwent major structural rearrangements once extracted from 
the mother subunit (Figure 37).  
 
 
Figure 37 First and final snapshots of the simulation of Peptide 3 in complex with FtsZ. 
 
By plotting the RMSD calculated on α-carbons vs. time (Figure 38), one 
can clearly observe that the peptide progressively lost its initial structure. As a 
consequence, the observed rearrangement led to a progressive weakening of 
peptide’s interactions with FtsZ, as can be pointed out by calculating how the 
free energy of binding varies through the simulation time (Figure 39). 
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Figure 38 RMSD calculated on Peptide 3 α-carbons throughout the simulation. 
  
 
Figure 39 Binding free energy calculated on Peptide 3 - FtsZ complex during the simulation. 
 
Whereas in the initial stages of the simulation, the ΔG value ranges around -40 
kcal/mol, at the end of the trajectory it turns to ca. -15 kcal/mol, clearly showing 
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 that only a small part of the interactions which originally made the association 
possible is left. In order to understand how the contribution of the single 
residues changed with respect to the dimer, a computational alanine scanning 
was performed (Figure 40).  
 
 
Figure 40 Results of the computational alanine scanning performed on the Peptide 3 - FtsZ complex. 
  
The results showed that Arg91’ still kept its hot-spot character, but the 
ΔG values of all the other amino acids turned to zero. Also Glu88’, which 
apparently turned to hot-spot (with a ΔΔG value of 3.26 ± 4.23 kcal/mol), 
actually had no significant and stable contribution, if one takes into account the 
high standard deviation associated to its ΔΔG value.  
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6.4 Cyclic peptides 
Based on the computational analyses, Peptide 1 and Peptide 2 therefore 
seemed to be the most promising ones in perspective of the design of molecules 
able to inhibit FtsZ-self association, since they retained the main interactions 
observed in the analysis of the FtsZ dimer interface. Nonetheless, the attention 
was subsequently focused on the optimization of Peptide 1, rather than Peptide 
2. In fact, Peptide 1 peculiar helical secondary structure made it particularly 
interesting, since it offered an ordered and stable scaffold for the proper 
orientation of the side chains involved in the interaction with FtsZ. On the other 
hand, the linear structure of Peptide 2 suggested that it could undergo large 
structural rearrangements when in solution, so it was reasonably less likely to 
adopt the correct geometry for binding. In order to check whether Peptide 1 
could preserve its helical structure even in solution, i.e. not bound to FtsZ, a 40 
ns molecular dynamics simulation was performed on the peptide in explicit 
water, monitoring its behaviour throughout the trajectory. It turned out that 
Peptide 1 had a tendency to lose its helical structure in solvent, as can be 
pointed out by observing the first and the last snapshot of the simulation 
(Figure 41). As a consequence, the side chains of the warm- and hot-spots lost 
the proper orientation for a correct binding of Peptide 1 to its putative binding 
site.  
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Figure 41 Starting (a) and final (b) snapshots of the simulation performed on Peptide 1 in solution. 
The secondary structure is clearly lost throughout the simulation. 
 
The attention was thus focused on the identification of a way to 
constrain Peptide 1 in its native helical structure, so to make it retain the proper 
conformation for binding. By analysing the results of the simulation performed 
on Peptide 1 in complex with FtsZ, it was found out that Asp178, belonging to 
the peptide, could establish a hydrogen bond with Ser182 or, alternatively, by 
differently orienting its side-chain, with Ser175. These residues did not interact 
with the facing FtsZ subunit neither in the dimer nor in the protein-peptide 
complex and could lead to the formation of a virtual ring involving all the 
amino acids between Asp178 and Ser182 in one case and between Ser175 and 
Asp178 in the other case, giving a hint on how to constrain the helical structure 
with simple chemical modifications. In fact, a ring was obtained by mutating in 
silico Ser182 into an ornithine and cross-linking its side-chain with that of 
Asp178 through an amide bond, so obtaining a cyclic peptide, named Peptide 
1a (Figure 42b).  
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In the same way, Ser175 was mutated into ornithine and cross-linked to 
Asp178, so obtaining a further cyclic peptide called Peptide 1b (Figure 42c). 
 
 
Figure 42 Peptide 1a (panel b) and Peptide 1b (panel c) were obtained from Peptide 1 (panel a) by 
mutating in silico Ser182 or Ser175, respectively, into an ornithine and cross-linking them to Asp178. 
 
 The design of cyclic peptides seemed a good approach to optimize and 
constrain the secondary structure of Peptide 1. In fact, cyclization is typically 
the first step in the optimisation of a peptide because it allows to restrain its 
conformational freedom, thus increasing the population of the active 
conformations, which exhibit the greater binding affinity with the target, and 
can moreover increase binding affinity reducing the entropic cost of peptide 
binding.  
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 The so-obtained peptides were simulated for 40 ns in solution, to 
evaluate if the cyclization actually improved the native helical structure 
stability. For both peptides, it turned out that the helical conformation was 
highly stabilized by the proposed modification, as can be pointed out by 
observing the final structures of the simulations (Figure 43 and Figure 44), with 
a great improvement with respect to the simulation of Peptide 1, which 
underwent major structural rearrangements.  
 
Figure 43 First and final snapshots of the simulation of Pepide 1a in solution. 
 
Figure 44 First and final snapshots of the simulation of Pepide 1b in solution. 
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The calculation of the RMSD on α-carbons calculated for both the linear and the 
cyclic derived peptides clearly confirmed that the backbone is more stabilized 
for Peptide 1a and Peptide 1b (Figure 45). Given the good results obtained on 
the peptides free in solvent, Peptide 1a and Peptide 1b were later on simulated 
for 5 ns in complex with FtsZ, positioning them in the same binding site of 
Peptide 1, in order to evaluate whether the modifications, though stabilizing the 
peptides in solution, could affect their binding to the protein. It turned out that 
the modifications did not weaken the interactions of the peptides to FtsZ, but, 
on the contrary, the binding resulted to be even slightly improved, with respect 
to the original Peptide 1 (Figure 46). The average ΔG of binding was -26.65 ± 
3.19 kcal/mol for Peptide 1b and -22.42 ± 5.44 kcal/mol for Peptide 1a.  
 A computational alanine scanning was then performed for both the 
cyclic peptides, confirming that the contribution of the single residues to the 
binding is on the whole not affected, with respect to Peptide 1 (Figure 47). It is 
important to point out that Met177 in both cases had its ΔΔG value noticeably 
increased, since in the cyclic peptides it can orient more properly towards the 
facing residues to establish stronger hydrophobic interactions which contribute 
to the stabilization of the complex. The stabilized helical structures thus 
provided the right scaffold for the orientation of the ‚hot-triad‛ composed of 
Met177, Phe180 and Arg181 towards their partner of interactions (Figure 48). 
Peptide 1a and Peptide 1b thus resulted to have the optimal features with 
regards to both the secondary structure stability in solution and the binding to 
the FtsZ-FtsZ interface. 
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Figure 45 RMSD calculated on α-carbons of Peptide 1, Peptide 1a and Peptide 1b in solution. 
 
 
 
Figure 46 Binding free energy calculated for the simulations of Peptide 1, Peptide 1a and Peptide 
1b in complex with FtsZ. 
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Figure 47 Comparison between the computational alanine scanning performed on the cyclic 
peptides and Peptide 1. 
 
 
Figure 48 The cyclization allowed the stable and efficient orientation of the key hot-spots towards 
their partner of interactions on the facing FtsZ subunit. 
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In order to confirm the computational results, Peptide 1a and Peptide 
1b were synthesized and underwent biological assays to evaluate their activity 
over FtsZ polymerization in vitro. Peptide 1 was also taken into account for 
comparison. The synthesis of the peptides was performed by Prof. Giovanna 
Speranza and Dr. Pierangelo Francescato of the Department of Organic and 
Industrial Chemistry of University of Milan. As to the biological tests, the 
analyses were carried out by Prof. Jayaraman, Dr. Chacko Jobichen and Dr.  
Prerna Domadia of the University of Singapore. 
 
 
 
Chapter 7 
Biological assays 
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7.1 GTPase activity tests 
As mentioned in Chapter 3, FtsZ polymerization is strictly GTP 
dependent and its dynamics is closely linked to the rate of GTPase hydrolysis. 
Therefore, monitoring the amount of inorganic phosphate (Pi) released upon 
treatment of FtsZ with peptides can provide a direct monitoring of the rate and 
extent of inhibition of FtsZ polymerization.  
 
Figure 49 Time course of GTPase activity with or without addition of peptides. Error bars represent 
the standard error of the mean.  
 
As can be seen in Figure 49, upon induction of GTP hydrolysis in 
control FtsZ, Pi molecules released were seen to initially increase up to 10 min. 
Thereafter, a steady-state phase up to 60 min was attained as hydrolysis rate 
plateau due to GTP consumption. GTP exhaustion and disassembly of FtsZ 
polymers was not observed up to 60 min in assay run in the absence of 
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 peptides. However, upon treatment of FtsZ with both Peptide 1 and the cyclic 
peptides, a strong perturbation of the GTPase activity of FtsZ assembly was 
observed. The linear peptide strongly inhibited the GTP hydrolysis from the 
values of 4.72 ± 0.95 min-1 in the absence of the peptide to -0.19 ± 0.42 min-1. 
Peptide 1a significantly abolished the initial rate of GTP hydrolysis of FtsZ 
assembly from the value of 9.09 ± 0.72 min-1, calculated in the absence of 
peptide, to the value of -0.15 ± 0.15 min-1 in the presence of peptide. Peptide 1b 
totally suppressed the rate of GTP hydrolysis by FtsZ assembly from the values 
of 4.72 ± 0.95 min-1, 6.15 ± 2.0 min-1 and 5.45 ± 1.75 min-1 in the absence of 
peptide to -0.89 ± 0.75 min-1, -0.11 ± 0.72 min-1 and -0.08 ± 0.59 min-1 at 20 min, 40 
min and 60 min, respectively. Concomitantly, at 5 µM, all three peptides 
remarkably inhibited the extent of GTP hydrolysis of FtsZ by 100 %, showing 
that both the linear and the cyclic peptides were able to impede the FtsZ 
dynamics. 
 
 
7.2 Transmission Electron Microscopy 
Further analyses were carried out to explore the effect of the peptides 
on the FtsZ assembly and identify the related changes in polymer morphology. 
Transmission electron microscopy (TEM) imaging of E.coli FtsZ was thus 
performed. E.coli FtsZ protein was incubated with or without peptide and 
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visualized for EM imaging (Figure 50). Control FtsZ readily assembled into 
abundant, thick, dense polymeric network of protofilaments (Figure 50a).  
 
 
Figure 50 Visualization of FtsZ assembly with or without addition of peptides by TEM. Electron 
micrographs of negatively stained FtsZ polymers were observed under a transmission electron 
microscope at ×50000 magnification, shown in the absence (A) and presence of 5 μM linear peptide 
1 (B) 5 μM cyclic peptide 1b (C) and 5 μM cyclic peptide 1a (D).  
 
However, 5 µM of all three peptides could readily prevent the 
formation of thick, dense filamentous crowding. The linear Peptide 1, after 5 
min showed very few, less dense, isolated, thin and curved FtsZ polymers. This 
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 peptide showed substantial reduction in the degree of forming protofilaments 
(Figure 50b). However, in the presence of Peptide 1b, polymer morphology was 
clearly perturbed. It resulted into formation of less frequent, remarkably thin 
and curved, shorter FtsZ (Figure 50c). Peptide 1a could not form FtsZ higher 
order assemblies such as bundles or extensive network of protofilaments after 5 
min. Few remains of very thin and markedly short, single stranded, strikingly 
curved polymers were searched and selectively imaged using a bar scale of 500 
nm (Figure 50d) instead of scale bar of 1 µm as used for the other images.  
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As in the study performed in the Part I, a computational approach allowed a 
detailed insight of the network of interactions occurring at the interface 
between proteins. Nonetheless, in the case of the FtsZ dimer, the study was not 
only limited to a deeper understanding of the mechanism of protein self-
association, but the gathered data were used for the design of effective inhibitor 
agents. In fact, the analysis allowed the design of a set of peptides, starting from 
the amino acidic sequence of contiguous hot-spots highlighted at the interface, 
able to bind FtsZ and modulate its polymerization. In particular, Peptide 1 was 
the subject of further optimizations aimed at the improvement of its binding 
ability to FtsZ. Peptides effectiveness was verified by biological assays in vitro, 
so proving the reliability of the computational approach in the study of protein-
protein interactions. 
 
Part II 
Conclusions 
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8.1 Halogen bond definition 
Halogen bonds (Figure 51) are particular interactions established by 
halogen atoms which present similarities with hydrogen bonds [133] [134] [135] 
[136] [137].  While the hydrogen bond can be schematically represented as D–
HA, where D and A denote respectively the donor and the acceptor group 
(behaving as a Lewis base), the halogen bond can be represented as D–XA 
where X is an halogen atom, with the force of the interaction growing up with 
the dimensions of the halogen (F << Cl < Br < I).  
 
 
Figure 51 Schematic representation of a halogen bond. 
The angle Θ is found to be close to 180°, whereas the 
distance between the halogen and the acceptor group 
(an oxygen atom in the example shown) is below the 
sum of the van der Waals radii of the atoms involved. 
Chapter 8 
Halogen bonds 
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It is well known that hydrogen bonds are of fundamental importance in 
determining the three-dimensional structure of biomolecules and in molecular 
recognition processes. For example, -helices and -sheets motifs in proteins, 
and helices in DNA and RNA are due to a well-defined network of hydrogen 
bonds. The formation of ligand-protein complexes is also frequently ascribable 
to the possibility to establish hydrogen bonds between the two partners of the 
complex. More recently, the importance of halogen bonding in biological 
systems has been as well evidenced [138] [139] [140] , due in part to the 
increasing number of resolved protein structures with halogenated ligands. 
Voth et al. have also demonstrated that halogen bonds can compete with 
hydrogen bonds in stabilizing DNA junctions using brominated uracil [141]. It 
should also be noted that a large number of currently used drugs are halogen-
substituted. Halogen atoms are many times introduced in a drug to increase its 
half-life, so as to prolong its activity in the organism, or to facilitate the 
membrane permeability so as to permit the drug to reach its biological target.    
The growing attention towards halogen bonding and a correct 
interpretation of its nature are now being aimed at increasing the activity of the 
ligands. For example, a systematic study of the importance of halogen bonding 
in novel inhibitors of human Cathepsin L has been recently reported [142], 
showing that it was possible to increase the activity of a ligand of almost two 
orders of magnitude, by substitution of a hydrogen with an iodine atom. 
Besides the biological aspects, halogen bonding was also exploited by 
several research groups as a tool to direct intermolecular recognition processes 
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 with applications in crystal engineering [143], in the development of solid state 
materials with electronic properties, ranging from organic semiconductors to 
superconductors [144] [145] [146] and also in the development of new materials 
with non-linear optical properties [147]. 
 
 
8.2 Electrostatic potential anisotropy around 
halogen atoms 
A simple interpretation for the formation of halogen bonds was given  
by Politzer et al. [148] [149]. The electrostatic potential of any neutral spherical 
atom is always positive at any distance from the nucleus, and this can be seen 
as the predominance of the concentrated nuclear charge over the dispersed 
electron cloud. Taking into account the valence electronic structure of a halogen 
atom covalently bonded to another atom along the z-axis, sketched as 
s2px2py2pz1, it is found that, with respect to the spherical isolated halogen atom 
(with a 5/3 mean population of p electrons in each direction), there is a 
depletion of electronic charge along the bond axis, in particular in the region 
outwards the covalent bond. Such a depletion is compensated by an increase of 
electronic charge in the directions perpendicular to the bond axis. Based on this 
interpretation, Politzer was able to explain the strong anisotropy of the 
electrostatic potential around a covalently bonded halogen atom, as obtained by 
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ab initio methods. A region of positive electrostatic potential, called -hole 
(Figure 52), is in fact built up on the halogen in the region outwards the 
covalent bond and a crown of negative electrostatic potential is built up around 
the direction of the D–X  bond.  
 
Halogen atoms are therefore able to accept electron density from a Lewis 
base located along the extension of the D–X bond, giving rise to halogen 
bonding. The size of the positive electrostatic area is found to depend on the 
electron withdrawing capabilities of the D group and on the nature of halogen 
atoms (this feature will be discussed in more detail in Chapter 10). The 
extension of the -hole is in fact more pronounced for the iodine atom, owing to 
its larger polarizability, decreases for bromine and chlorine atoms, and then 
disappears for the fluorine atom, except in the presence of strongly 
electronegative D groups. Moreover, a positive correlation has been reported 
between the value of the electrostatic potential on the -hole and the strength of 
the halogen bond [148] [149] [150]. 
Figure 52 In halogenated ligands, a positive cap (σ- hole) on the electrostatic  potential is found 
around the halogen atoms, outwards the C-X bond.  
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 8.3 Halogen bonds in molecular mechanics 
A rigorous theoretical description of halogen bonding can be obtained 
using quantum mechanical methods like MP2 or DFT. However, these methods 
cannot be applied to the study of very large molecules such as halogen-
containing biological systems. In these cases, it is mandatory to use the so-called 
hybrid methods, based on the partition of the entire system into a small region 
which contains the halogen bonds and that can be described by quantum 
mechanics methods (QM), and the remaining atoms which constitute the 
majority of the system, that can be described by molecular mechanics methods 
(MM). For example, QM/MM methods in the ONIOM [151] [152] [153] 
implementation have been recently successfully applied to the description of 
different protein-halogenated ligand complexes whose structure had been 
determined by X-Ray methods [154]. 
In order to describe the dynamical behaviour of such complexes and to 
evaluate different docking poses, it would be desirable to have the possibility to 
model the full system by resorting to only molecular mechanics methods. Up to 
now, the problem to describe the electrostatic potential around the molecule in 
the framework of most MM methods used to describe large molecules of 
biological interest has been solved by using single point charges cantered on 
atomic positions. Such an approach, however, does not allow to describe the 
anisotropy of the potential around the halogen atom. More sophisticated 
methods based on multipolar approaches could overcome the problem, but 
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they are evidently more demanding from a computational point of view. The 
development of simpler approaches then appears to be highly desirable.   
In this part of the work, a simple strategy to correctly describe, by MM 
methods, halogen bonding in biological systems was searched. Attention was 
focused on interactions where iodine or bromine atoms are involved, as they 
give rise to the stronger halogen bonds. The approach consisted in introducing 
a pseudo-atom located along the D–X bond, outwards the bond itself, and to 
use this extra point to correctly fit the electrostatic potential around the 
molecule (Figure 53). 
 
Figure 53 Using the proposed approach to describe the σ-hole in molecular mechanics, a point 
charge (represented in yellow) is added on the extension of the carbon-halogen bond, in order to 
better fit the electrostatic potential in that particular region. 
  
It is to be noted that the introduction of extra-points was already used 
in the force field methods to describe anisotropies, for example those due to the 
presence of lone pairs of electrons [155] [156]. Following strategies already 
implemented for taking into account such ‘extra-points’ [155] [156], the pseudo-
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 atom can be linked with an harmonic potential to the halogen atom. In this 
way, it could be possible to reproduce the -hole and the full anisotropy of the 
potential around the halogen atoms, that was pointed out by Politzer to be 
responsible of the formation of halogen bonding [148] [149] .Therefore, by 
simply introducing a little variation in the traditional force field, halogen bonds 
in biomolecules could be adequately reproduced by molecular dynamics  
simulations. In order to validate the results obtained through this approach, a 
comparison with both crystallographic structures and QM/MM optimization 
had to be performed.  
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9.1  Pseudo atom parametrization 
As mentioned before, halogen bonds are mainly due to an electrostatic 
interaction between the positive -hole, i.e., a region of positive electrostatic 
potential located on the halogen atom X in the direction of the  D–X bond, and 
an acceptor atom acting as a Lewis base. This interaction brings the distances 
between the halogen and the acceptor atoms below the sum of their van der 
Waals radii. The electrostatic interaction in a force field is usually described 
attributing a point charge on each atom. While charges for the atoms of each 
amino acid are provided by the developers of the force field, charges of the 
ligands can be determined by means of a fitting of the electrostatic potential 
determined at the quantum mechanical level, following the so-called Restrained 
ElectroStatic Potential (RESP) procedure [157]. 
Describing halogen bonds 
in molecular dynamics 
Chapter 9 
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In Figure 54, the electrostatic potential obtained at different levels for 
halogenated ligands, e.g. K44 and I3C, respectively a bromo- and an iodo-
derivative (panels a and e; see Figure 55 for the chemical structure of the 
ligands) is shown. The QM electrostatic potential of the two ligands (panels b 
and f, respectively) clearly showed a strong anisotropy around each halogen 
atom. The -hole was clearly visible and appeared to be more pronounced for 
the iodine with respect to the bromine atom, in agreement with the above-
mentioned trend observed for the strength of halogen bonding. A fitting of the 
electrostatic potential by the RESP procedure simply using a single point charge 
on each halogen atom was carried out, and the electrostatic potential was 
recomputed using the set of derived RESP charges (panels c and g).  
 
Figure 54 Electrostatic potential mapped onto the surface of electron density (0.002 electrons/au3) of 
ligands K44 (a) and I3C (e), calculated at the QM level (b, f) or using the fitting by the RESP 
procedure without pseudo-atom (c, g) and after pseudo-atom addition (d, h). 
 
This is the electrostatic potential that would be traditionally used in a molecular 
dynamics simulation. It is evident that the -hole was not reproduced and that 
the electrostatic potential is poorly described around the halogen atoms.  
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 A pseudo-atom was thus added along the D–X bond located at a fixed 
distance from the halogen atom, to better fit the electrostatic potential around 
the halogen atoms and correctly describe anisotropic features [158]. The RESP 
procedure was then applied to determine the electrostatic charges also on the 
pseudo-atoms. The electrostatic potential computed from the new set of charges 
(panels d and h) was noticeably improved and showed the correct anisotropy, 
with a -hole well evident on the halogen atoms. The addition of a pseudo-
atom thus seemed to be a simple though efficient method to improve the 
description of the electrostatic potential and in particular to introduce those 
features which are responsible for the halogen bond formation The full set of 
parameters used to describe the pseudo- atoms are reported in Table 2. Their 
distances from the halogen atoms were chosen to give the best fit with the QM 
electrostatic potential.  
 
 
9.2 Molecular dynamics simulations 
Proven the effectiveness of the pseudo-atom approach in correctly 
describing the electrostatic potential for halogenated molecules, in order to 
investigate their role in describing halogen bonding arising in ligands bonded 
to a protein, a number of molecular dynamics simulations was performed on a 
set of halogenated ligand-protein complexes. 
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Table 2 Pseudo-atom parameters used for the MM force field. 
 
aX = bromine or iodine atom, PA = pseudo-atom. 
bThe equilibrium distance between halogen and pseudo-atom, Req, varies according to the best 
fitting with the electrostatic potential calculated at the QM level: 1.4 Å for the molecule BML, 1.6 Å 
for I3C and BRT, 1.7 Å for T44, T3 and 4HY and 1.8 Å for TBB and K44. 
cThe bond force constant, Kr, the equilibrium angle, Θeq, and the angle force constant, KΘ, are kept 
constant regardless of the ligand. The Van der Waals parameters of the pseudo-atom (r* , ε) are set 
to zero.  
 
 
The structures were retrieved from a recently published work on the 
importance of halogen bonding in the field of rational drug design [154] in 
which the authors analysed the entire Protein Data Bank (December 2008 
release) and collected a total of 248 structures where the distances between 
halogens and oxygen atoms are less than the sum of their respective van der 
Waals radii (which amount to 3.27 Å, 3.37 Å, 3.50 Å respectively for  ClO, 
BrO and IO contacts) and with a D–XO angle greater than 120°. It is to be 
noted that halogen bonds where the acceptor Y is an oxygen atom are 
particularly important in biochemistry, as they represent one of the most 
Parametera Value 
Mass 3.0 amu 
Req (X-PA)b 1.4 Å – 1.8 Å  
Kr (X-PA)c 600.0  kcal mol-1 Å-2 
Θeq (C-X-PA)c 180.0° 
KΘ (C-X-PA)c 150.0 kcal mol-1 Å-2 
r*c 0.0 Å 
εc 0.0 kcal mol-1 
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 common halogen bonds in protein-ligand interactions. Usually the oxygen 
involved in such interactions belongs to the protein backbone amidic group.  
From this set, four X-ray structures containing bromine atoms (PDB 
IDs: 1P5E [159], 1GXZ [160], 1T0S [161], 1ZOH [162]) were selected, two of 
which (1P5E and 1ZOH) established multiple halogen bonds. Five structures 
containing iodine atoms (PDB IDs: 1Y0X [163], 2H77 [164], 3E79 [165], 3E3T 
[166], 1NQ2 [167]) were also chosen. The selected structures contained 
halogenated ligands (Figure 55) in complex with particularly important 
proteins, like, for example, thyroid hormone receptors, kinase and cell division 
kinase proteins. 
For all these structures, molecular dynamics simulations were 
performed where the ligands were described with the addition of a pseudo-
atom for each halogen atom. For comparison, the same simulations were 
repeated without introducing the pseudo-atom. The mean values of the 
geometrical parameters of the halogen bonds are reported in Table 3. 
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Table 3 Geometrical parameters of C–XO halogen bonds in protein–ligand complexes from 
molecular dynamics simulations in the absence and in the presence of pseudo-atom on the halogen. 
 
 
   no pseudo-atom pseudo-atom 
PDB Id Ligand Halogen bonda d(XO) (Å) C–XO (°) d(XO) (Å) C–XO (°) 
1P5E TBB Br1 ∙∙∙ Phe80b 4.18 ± 0.49 142.9 ± 15.5 3.64 ± 0.32 148.7 ± 15.7 
  Br2 ∙∙∙ Glu81O 4.11 ± 0.47 139.1 ± 14.3 3.54 ± 0.50 162.5 ± 11.5 
  Br3 ∙∙∙ Leu83O 4.24 ± 0.91 129.7 ± 16.9 3.58 ± 0.48 150.9 ± 15.7 
1GXZ BRT Br ∙∙∙ Gln187O 3.86 ± 0.36 159.2 ± 7.5 3.43 ± 0.29 163.8 ± 7.4 
1T0S BML Br ∙∙∙ Glu231O 3.79 ± 0.64 150.6 ±10.0 3.33 ± 0.22 170.0 ± 6.0 
1ZOH K44 Br3 ∙∙∙Glu114O 5.31 ± 1.21 138.6 ±19.0 3.99 ± 0.45 142.7 ± 20.5 
  Br4 ∙∙∙Val116O 4.43 ± 0.91 153.2 ±19.8 3.51 ± 0.35 158.0 ± 5.2 
IY0X T44 I2 ∙∙∙Phe272O 3.62 ± 0.25 154.2 ± 8.6 3.48 ± 0.34 165.4 ± 7.9 
2H77 T3 I1 ∙∙∙Phe218O 3.64 ± 0.26 162.7 ± 8.5 3.43 ± 0.24 170.5 ± 5.4 
3E79 I3C I3 ∙∙∙ Ala334O 3.79 ± 0.32 117.7 ± 12.9 3.33 ± 0.25 124.3 ± 26.4 
3E3T I3C I3 ∙∙∙ Leu141O 12.18 ±2.96 32.7 ± 18.2 3.74 ± 0.62 151.5 ±16.9 
1NQ2 4HY I1 ∙∙∙ Phe272O 3.86 ± 0.29 150.1 ±7.8 3.46 ± 0.30 163.8 ± 7.8 
Figure 55 Chemical structures of the ligands considered in the molecular dynamics simulations. 
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 Molecular dynamics details 
The ligand-protein complexes structures were obtained from the Protein Data Bank (PDB 
codes: 1P5E [159], 1GXZ [160], 1T0S [161], 1ZOH [162], 1Y0X [163], 2H77 [164], 3E79 [165], 3E3T 
[166], 1NQ2 [167]). In the case of 1P5E, where two almost identical protein complexes were present 
in the crystal structure, the A chain was removed and only the B chain has been considered in 
calculations.The partial atomic charges for the ligands were derived using the Restrained 
ElectroStatic Potential (RESP) method [157], as implemented in AMBER11 [168]. For each halogen 
atom X, a pseudo-atom has been added along the direction of the D–X bond, in the region outward 
the bond itself. Its distance from the halogen has been determined to give the best fit with the 
quantum mechanical electrostatic potential.  The parameters used for the pseudo-atom are reported 
in Table 2. Atomic charges after  pseudo-atom addition were recalculated using the RESP module.  
Molecular dynamics simulations were performed with the AMBER11 package on all 
complexes both in the native form and after pseudo-atom insertion. The dynamics were run with 
periodic boundary conditions using the 2003 force field for the protein and the Generalized Amber 
Force Field (GAFF) for the ligands. Missing parameters were calculated according to Wang et al. [82] 
The systems were simulated in TIP3P explicit water solvent, adding sodium or chloride ions to get 
neutrality. The SHAKE algorithm was employed to constrain all bonds involving hydrogen to their 
equilibrium bond lengths, which allowed an integration step of 1 fs. All complexes underwent 1000 
steps of steepest descent minimization, followed by 9000 steps of conjugate gradient minimization 
with a 500 kcal mol-1 A-2 restraint on the position of protein backbone atoms and of all molecule 
atoms. A 100 ps NVT equilibration at 300K and a subsequent 100 ps NPT equilibration at 1 atm and 
300K were performed to ensure temperature and density equilibration. A 500 kcal mol-1 Å-2 restraint 
on the position of protein backbone atoms was applied during the equilibration phases. A 2 ns 
productive phase under NPT conditions (1 atm, 300K) was then performed using a 10 Å cutoff for 
non-bonded interactions and the Particle Mesh Ewald algorithm to calculate long-range electrostatic 
interactions. The systems were then cooled down to 0K at a 4 K ps-1 constant cooling rate to get a 
structure devoid of fluctuations, to be used for comparison with Quantum Mechanics/Molecular 
Mechanics (QM/MM) results and crystallographic structures.  
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It resulted that, in the presence of the pseudo-atom, shorter halogen 
bond distances and larger (i.e., closer to 180°) D–XO angles were achieved 
with respect to the corresponding values obtained by simulations excluding the 
use of pseudo-atoms. Both geometrical aspects can be easily ascribed to a 
proper description of the -hole, as allowed by the use of pseudo-atoms. It is to 
be noted that, also in the presence of the pseudo-atom, the XO distances 
happened to be significantly longer than the sum of their van der Waals radii, 
during the simulation, because the trajectories of molecular dynamics 
simulations are of course characterised by fluctuating distances. In order to 
reduce such fluctuations and to identify a value unaffected by a kinetic 
contribution, all the systems, after the production phase, were gradually cooled 
to a temperature T=0 K. The corresponding geometrical parameters are reported 
in Table 4 together with the crystallographic values. The results show that the 
simulation protocol with pseudo-atoms always provided smaller final halogen 
bond distances with respect to the corresponding simulations without pseudo-
atoms and the values were always less than the sum of the van der Waals radii. 
The obtained results compared also very well with the crystallographic values. 
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 9.3 QM/MM optimizations 
For comparison purposes, for each system, an extended series of 
QM/MM geometry optimizations was performed, where the QM part, treated at 
DFT level, was constituted by the ligand and the halogen-bonded residue(s). 
Different protocols were used in the QM/MM methodology, using different 
functionals and coupling schemes between the QM and the MM regions and 
including or not water molecules located near the ligands. Dr. Alessandra Forni 
(ISTM, CNR) is acknowledged for the support in the set-up of the calculations.  
QM/MM results, reported in Table 4, were quite scattered, depending 
on the protocol adopted in the calculations, but were overall closer to the results 
obtained in the presence of pseudo-atoms. The agreement was generally better 
for QM/MM results obtained with the electrostatic embedding approach, where 
the quantum mechanical region can be polarized by the MM region. 
Unfortunately, calculations in this case were more expensive with respect to the 
simpler mechanical embedding scheme and the geometry optimization was 
more problematic, resulting in some cases into convergence failure. Simulations 
performed in the absence of pseudo-atoms caused in several cases a complete 
disruption of the halogen bond interactions, while in some other cases the 
halogen bond distances were only slightly greater with respect to those 
obtained in the presence of pseudo-atoms. However, it is important to point out 
that the halogen bond interaction is strongly anisotropic due to the presence of 
the -hole, and a correct geometrical description of this interaction should be 
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characterized not only by the distance d(XO), but also by the angle D–XO. 
Taking this point into account, it resulted that in the cases where simulations 
without pseudo-atoms gave acceptable value in the halogen bond distances, 
generally the D–XO angles were poorly described. 
 
QM/MM optimization details 
QM/MM calculations were performed using the two-layer ONIOM model [151], [152] 
[153] as implemented in Gaussian09 [170]. The ligands and the protein residues halogen-bonded to 
the ligands were included in the QM layer, whereas the rest of the protein was included in the MM 
layer. Calculations were performed by either excluding water molecules or including those falling 
into a shell of 8 Å around the ligand as part of the MM layer. The QM part was treated at the DFT 
level with two functionals, B3LYP [171] [81] and MPWLYP [81] [172] , which had been previously 
proved to give satisfactory results in studying halogen bond properties [173]. The 6-311G* basis set 
was used for all atoms [174]. The Amber Force Field was chosen to describe the MM region. A well-
known critical point in QM/MM calculations [175] [176] [177] is the mutual electrostatic interaction 
between the mechanical and the quantum part. Calculations were thus performed using both the 
less expensive ‘mechanical embedding’ and the more sophisticated, even if more expensive, 
‘electrostatic embedding’. In the mechanical embedding, the mutual electrostatic interaction 
between the two layers is treated at the MM level. In this way the QM electron density cannot be 
polarized by the atoms of the MM layer. To describe this polarization, the ‘electrostatic embedding’ 
scheme can be adopted, where the point charges of the MM layer are included in the Hamiltonian 
of the QM layer, so introducing a polarization of the wave function. This results in a more 
expensive but more rigorous way to describe the interactions between the two layers. Each QM/MM 
calculation was carried out using, as starting geometry, the structure obtained at the end of the MD 
simulation (i.e., the structure at 0 K). Exceptions to this strategy were some ‘electrostatic 
embedding’ calculations afflicted by some convergence difficulties. In these cases the corresponding 
converged structure obtained with the ‘mechanical embedding’ calculation was used.  
Part III - Computational description of halogen bonding 
 
111 
 
 
 In order to appreciate the overall accuracy of the different 
computational protocols in the halogen bond description, distances and angles 
for each halogen bond considered were plotted (Figure 56). It is evident that the 
points obtained by molecular dynamics simulations using pseudo-atoms 
tended to cover the same area of crystallographic structures and QM/MM 
results, whereas simulations without pseudo-atoms were more scattered and 
characterized by the presence of some outliers.  
The stability of protein-ligand complexes, nevertheless, results from a 
sum of different contributions; in fact, the protein-ligand binding is almost 
always due to a network of different interactions [178] ,such as hydrogen and 
halogen bonds, hydrophobic contacts and van der Waals interactions. In some 
of the reported cases (e.g. 1T0S, 3E79, 3E3T, 1ZOH), a poor description of 
halogen bonding caused also a disruption of the other interactions and a 
consequent loss of the correct docking of the ligand. For example, the BML 
ligand in the 1T0S system, established, in addition to the halogen bond with 
Glu231, an hydrogen bond between the oxydrilic group and Glu265, and 
hydrophobic contacts between the ring of the BML molecule and the atoms of 
the hydrophobic portion of the chains of residues Arg256 and Lys258. All these 
interactions were correctly described if the simulation was carried out in the 
presence of the pseudo-atom. When pseudo-atom was absent, a strong increase 
of the halogen-oxygen distance (up to 5.2 Å) was observed, together with the 
disruption of the hydrogen bond and a movement of the residues Arg256 and 
Lys 258, bringing to a loss of the hydrophobic contacts. 
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In other cases (e.g. 2H77, 1NQ2, 1P5E), the absence of pseudo-atoms 
gave rise to less dramatic effects, since other interactions between the ligand 
and the protein, besides halogen bond, kept the ligand correctly docked in its 
crystallographic position. For example, the ligand T3 in the 2H77 system 
established, in addition to hydrogen and halogen bonds, a complicate network 
of hydrophobic interactions with different residues, namely Ile222, Leu292, 
Leu276, Met259 and Leu287. In the absence of pseudo-atoms, the distance 
between I1 and the oxygen of the Phe218 residue was only a little longer with 
respect to the value obtained by simulation with pseudo-atom (i.e. 3.41 Å 
instead of 3.28 Å). The hydrophobic contacts were preserved and the ligand 
was able to rearrange in the pocket. The incorrect description of the halogen 
bond was still certified by the D–XO angle value (161.78°), quite different 
from the crystallographic one (174.36°), which was instead adequately 
reproduced if pseudo-atoms were used (178.85°). A similar situation occurred 
for the 1NQ2 system. 
It is also worth noting that the use of the pseudo-atom also allowed, in 
the system 1P5E, the correct description of the interaction between Br1 and the 
phenyl ring of the residue Phe80. In this particular case, the π-cloud of the 
aromatic ring could act as an acceptor group in the place of an oxygen atom, 
leading to the formation of an aromatic halogen bond. In the presence of the 
pseudo-atom, the distance between the bromine atom and the phenyl ring 
turned out to be very close to both the crystallographic value and that obtained 
by QM/MM calculations. 
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Table 4 Geometrical parameters of C–XO halogen bonds in protein–ligand complexes from 
molecular dynamics (MD) simulations at T=0 K in the absence and in the presence of pseudo-atom on 
the halogen, from X-ray crystal structure and from QM/MM calculations with B3LYP or MPWLYP 
functional, in the absence and in the presence of water molecules, and with mechanical or 
electrostatic embedding.a 
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 9.4 Complex K44 – protein kinase CK2 
Among the systems studied, it is very interesting to observe the 
dynamical behaviour of the 1ZOH structure, where the ligand K44 possessed 
four adjacent bromine atoms (Br1 to Br4). During the MD simulation of 2ns, the 
ligand K44 kept for almost the whole dynamics the conformation observed in 
the crystal structure, where the molecule established hydrophobic interactions 
(with the residues Ile66 and Ile174) and two halogen bonds involving Br3 and 
Br4 with, respectively, the carbonyl oxygens of the peptidic bond of Glu114 and  
Val116 (Figure 57a). Occasionally, the ligand underwent a small rotation, so as 
to give rise to new halogen bonds, involving Br3 and Br2 and the same residues 
(Figure 57b) still preserving the hydrophobic interactions with Ile66 and Ile174. 
 
 
Figure 57 Comparison between the conformation A (a) and B (b) adopted by the ligand K44 during 
the molecular dynamics simulation (green dashed lines indicate the halogen bonds with the 
residues Glu114 and Val116; red dashed lines indicate the hydrophobic interactions with the 
residues Ile66 and Ile174). 
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The cooling to 0 K was conducted for both conformations, giving rise to 
two different final conformations denoted as A and B in Table 4. It is to be 
noted that the protein of the 1ZOH system is kinase2 (CK2), which has been 
crystallized with different ligands besides K44. In one of these structures (PDB 
id: 1ZOG [162] [179]), the ligand is a tetrabromo-benzimidazole derivative, like 
K44, which is found to crystallize into two different poses, corresponding to the 
two conformations obtained for the ligand K44. Interestingly, the maximum 
values assumed by the electrostatic potential on the electron density isosurface 
in the -hole regions had the following ratios: 1:0.74:0.66:0.60 (Br4:Br3:Br2:Br1). 
Accordingly to Politzer [149], a similar relationship in the strength of the 
interactions that each halogen atom can establish with the protein residues 
could be expected.  This explains why the dynamics well described the 
crystallographic conformation involving the two halogens with the most 
prominent -holes, Br4 and Br3, but occasionally the molecule could shift 
toward another conformation involving Br3 and Br2. This supported the 
existence of two different energy minima which were both explored by the 
simulation with pseudo-atoms. QM/MM calculations confirmed the presence of 
such two minima, with the second conformation characterized by longer 
halogen bond distances. On the other hand, the simulation of the 1ZOH system 
without pseudo-atoms was not able to describe any of the two conformations, 
since the distances between bromine and oxygen atoms were always found 
much longer than the sum of their van der Waals radii. These results provided a 
further proof of the importance of including the pseudo-atom on the halogen 
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 atoms to get a proper description of the conformations of the ligands and of 
their relative stability. All these results indicate that the use of pseudo-atoms 
located along the D–X direction, in such a way to optimize the fitting with the 
electrostatic potential obtained at the quantum mechanical level, is a simple and 
viable strategy to perform molecular dynamics simulations of halogen bonded 
systems, using traditional force fields based on atom-centred charges.  
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In order to deepen the knowledge on the geometrical and energetic 
features of halogen bonding, a systematic theoretical study of the solvation 
effects on this interaction was also performed. In fact, up to now, only few 
theoretical investigations of the solvent effect on the halogen bond properties 
can be found in literature [180] [181] [182]. 
As model system, dimers constituted by differently substituted 
iodobenzene with formaldehyde in two solvents (diethylether and water) were 
taken into account for QM calculations, in order to evaluate differences in 
geometry and energy moving from vacuo to solvent. The choice of 
formaldehyde as acceptor group was due to the fact that a survey [154] of 
protein-halogenated ligand complexes evidenced the frequent occurrence of 
halogen bonding with oxygen atoms of a peptidic bond. In our case, the 
attention was focused on iodine-based halogen bonds, since they are 
Solvent effect on 
halogen bonding 
Chapter 10 
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characterized by the stronger interaction energies, allowing to better elucidate 
the variations observed when moving from vacuo to solvent. Different schemes 
of substitution were used, aimed at modulating the force of  the halogen bond, 
from weak to moderate interaction.  
Calculations were carried out at both the MP2 level, in order to 
adequately describe the electronic correlation effects, and the DFT level using 
two different density functionals, in order to evaluate their ability to reproduce 
the effects of the solvents in the description of the halogen bond (see the 
Materials and Methods box for more details). 
 
 
10.1. Gas-phase calculations 
A first set of calculations was performed in vacuo on a series of 
halogen-bonded complexes of variously substituted iodobenzene with 
formaldehyde (see Table 5 for the list of compounds taken into account). 
Different substitution schemes on iodobenzene were used as a simple way to 
modulate the strength of the interaction with formaldehyde. The same 
approach was followed by Riley and Merz [180] in their study on the strength 
and origin of halogen bonding. The halogen bond interaction energies and 
geometrical parameters of the optimized geometries at different theoretical 
levels are listed in Table 5. 
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Materials and methods 
All ab initio calculations were carried out using the Gaussian ’09 program [170]. Full 
geometry optimization were performed by the ab-initio second order Möller-Plesset perturbation 
(MP2) method [183] and density functional theory (DFT) using two widely used functionals, 
namely B3LYP [171] [81] and PBE [184].  The aug-cc-pVDZ-PP basis set [185], which uses 
pseudopotential to describe the inner core orbitals, was used for iodine, whereas for all other atoms 
the aug-cc-pVDZ basis set [186] was adopted. These basis set have already shown to be of good 
quality to describe various halogen-bonded systems [150] [173] [187]. All the minimum geometries 
were confirmed by verifying that all vibrational frequencies at the MP2 level are real. Solvent effects 
have been taken into account using the CPCM polarisable conductor calculation model [188]. 
The interaction energy E was computed as the difference between the energy of the 
dimer and the sum of the energies of the monomers at the geometry assumed in the dimer. In order 
to take into account the Basis Set Superpostion error (BSSE), the values of interaction energy 
obtained in vacuo were corrected with the Boys and Bernardi procedure [189], to give the 
counterpoise corrected interaction energies ECP. The BSSE correction term evaluated in vacuo was 
also used to correct the interaction energies evaluated in solvent calculations as reported in [180] 
 
In Figure 58, the electrostatic potential computed on an isosurface of 
electron density of 0.001 au, according to the Bader’s suggestion [190], is 
reported for a subset of iodobenzene derivatives, p-amino-iodobenzene (top), 
m-chloro-iodobenzene (middle) and pentafluoro-iodobenzene (bottom). In all 
the cases, it is well evident the anisotropy of the electrostatic potential around 
the halogen atom, responsible for the formation of halogen bonding. In 
particular, it is well represented the -hole, located in the direction of the D–X 
bond, responsible for the interaction with an oxygen’s lone pair of 
formaldehyde. 
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Moreover, from Figure 58 it can be qualitatively observed that the 
introduction of electron-withdrawing groups on iodobenzene increased the 
extension of the σ-hole on the iodine atom. This corresponds to increasing (i.e., 
more negative) interaction energies, from -2.25 to -2.57 and then to -3.93 
kcal/mol (MP2 values corrected for BSSE) on going from p-amino- to m-chloro- 
and pentafluoro-iodobenzene. In general, it can be observed from Table 5 that 
the interaction energies depended on the nature, number and position of the 
substituent(s) on the ring: stronger halogen bonds were in fact observed with 
increasing the strength of the electron-withdrawing groups (compare e.g. p-
Figure 58 Electrostatic potential mapped onto the surface of electron density (0.001 electrons/bohr3) 
for p-amino-iodobenzene, m-chloro-iodobenzene and pentafluoroiodobenzene: the extension of the -
hole increases with the introduction of electron withdrawing groups on the benzene ring. 
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chloro-iodobenzene with p-cyano-iodobenzene, ECP=-2.57 and -2.83 kcal/mol, 
respectively, at MP2 level), the number of substituents (compare e.g. 3,5-
difluoro- with 3,4,5-trifluoro and pentafluoro-iodobenzene, ECP=-2.82, -2.98 
and -3.93 kcal/mol, respectively), and with changing the position of the 
substituents (compare e.g. p-amino- with o-amino-iodobenzene, ECP=-2.25 and 
-2.54 kcal/mol, respectively). Such dependencies, as already qualitatively 
observed in Figure 58, are ascribable to the different anisotropy of the 
electrostatic potential around the iodine atom, and in particular on the nature of 
the -hole, as originated by the different substituents on the ring.    
By comparing the different methods of computation, it turns out from 
Table 5 that, taking the MP2 results as a reference, the interaction energies 
computed at DFT level were in all cases underestimated. Moreover, the PBE 
functional appeared to better reproduce the MP2 results with respect to B3LYP. 
Average absolute deviations interactions energies were in fact 0.24 and 1.10 
kcal/mol for the PBE and the B3LYP functionals, respectively. 
Moreover, it is to be pointed out the entity of the CP correction was in 
all cases very large despite the quite extended basis set used in these 
calculations. This was in particular true as far as the MP2 results were 
concerned. For example, for the weaker interaction considered in this study 
(dimer 1, see Table 5 for the numbering of the compounds) the error due to 
BSSE was 43%, 16% and 26% of the uncorrected energy at MP2, PBE and B3LYP 
levels, respectively. It is however to be noted that such correction was quite 
independent on the system studied: it ranged from 1.72 to 1.76 kcal/mol for 
Part III - Computational description of halogen bonding 
 
125 
 
 
 dimers 1-9 (1.88 kcal/mol for 10) at MP2 level, and from 0.29 to 0.41 kcal/mol 
for 1-10 at both DFT levels.  
In Table 5, the geometrical parameters of halogen bonding in the 
different dimers examined are also reported. In all cases, the IO distances 
were well below the sum of the van der Waals radii of iodine and oxygen [191], 
amounting to 3.50 Å, and, as expected, decreased regularly with increasing the 
strength of the interaction. Taking again the MP2 results as a reference, the 
B3LYP functional tended to overestimate the IO distances, especially for the 
weaker interactions. The PBE functional instead provided both larger and 
smaller IO distances with respect to the MP2 ones, but with a better overall 
agreement with the latter values with respect to B3LYP. In fact, the average 
absolute deviations of the distances amounted to 0.101 and 0.021 Å for the 
B3LYP and the PBE functionals, respectively. The angle C–IO was always 
close to linearity and the deviations with respect to 180° tended to reduce with 
increasing the halogen bond strength at all levels of theory used. DFT 
calculations gave generally wider angles with respect to MP2. Once again, the 
PBE functional appeared slightly better with respect to the B3LYP one. Average 
absolute deviations for the C–IO angle were 1.8° and 1.3° for B3LYP and PBE, 
respectively. Finally, a slight, though not systematic, shortening of the C–I bond 
length was observed with increasing the strength of halogen bonding, which 
was reproduced by all computation methods. It amounted to 0.017 Å at all 
levels of theory on going from dimer 1 to dimer 10.  
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10.2 Solvent calculations 
Owing to the importance of the electrostatic contribution in halogen 
bonding, it is to be expected that solvent would have a non-negligible influence 
on the physical chemical properties of this interaction. To describe such 
solvation effects, the PCM model was used, where the solvent is treated as a 
uniform medium characterized by its dielectric constant. All the systems were 
optimized in two solvents, namely diethylether, whose dielectric constant 
=4.24 is very close to the value existing at the interior of a protein [192], and 
water (=78.36). The interaction energies and the geometrical parameters of the 
optimized structures obtained using the PCM model are reported in Table 6 
and Table 7 for calculations in diethylether and in water, respectively.  
From the energetic point of view, the solvent systematically reduced the 
strength of the interaction, and the reduction was more pronounced with the 
increase of the dielectric constant. Moreover, the strength order observed in 
vacuo remained unaltered when moving to solvent. Though in absolute value 
the stronger halogen bonds underwent a greater decrease in the interaction 
energy with respect to the weaker ones, the opposite trend was observed when 
considering the relative variations. For example, at MP2 level, ECP of dimer 1 
decreased by 0.64 and 0.83 kcal/mol (i.e., 28% and 37%) in diethylether and in 
water, respectively, while for dimer 10 it decreased by 0.85 and 1.14 kcal/mol 
(i.e., 22% and 29%) in diethylether and in water, respectively. This tendency 
was as well observed at both DFT levels of theory. 
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From the geometrical point of view, on the other hand, the presence of 
the solvent implied a systematic decrease in the IO distances at all theoretical 
levels, as previously reported for other halogen bonded dimers [182]. Moreover, 
an increase (towards 180°) of the C–IO angle was observed on going from 
vacuo to diethylether and then to water. The mean reductions of the IO 
distances from vacuo to diethylether were 0.017 Å for MP2 and B3LYP 
calculations, and 0.033 Å for PBE calculations. The corresponding mean 
increases for the angle values were 3.5° for MP2 and 4.3° for both DFT 
calculations, leading to halogen bonds very close to the linear arrangement. The 
corresponding variations from vacuo to water were 0.021, 0.040, 0.018 Å and 
4.7, 5.1 and 5.4° for MP2, PBE and B3LYP calculations, respectively. 
Interestingly, the reduction in the distances and the greater tendency to 
linearity observed when going from vacuo to solvent were then not correlated 
to an increase of the strength of the interaction, as could be naively expected. In 
other words, for a same halogen bond distance and angle, a much weaker 
interaction should be expected in solvent with respect to the gas phase. 
The decrease of the IO distances in solvent with respect to vacuum 
was always accompanied by a slight increase of the C–I bond lengths. The 
relationships between the variations of the IO and the C–I distances has been 
already observed for hydrogen bonded systems [193], for which it has been 
interpreted as a nonadditivity/polarization effect in PCM calculations [181]. It 
has also been reported that the distance IO in the dimer iodobenzene/water is 
further reduced if one or two explicit water molecules, hydrogen-bonded to the 
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 water molecule acting as halogen bond acceptor, are added to the dimer [182]. 
This further confirms the solvent effect on the halogen bonding geometry. It 
also resulted that, while the PBE functional appeared superior to the B3LYP one 
in reproducing absolute values of energy or geometrical parameters, their 
variations were well reproduced by both functionals, evidently for a 
cancellation of errors.  
In Figure 59 (top) is reported a plot of the strength of halogen bonding 
against the maximum value assumed by the electrostatic potential, computed at 
the MP2 level, on the isosurface of electron density (0.001 au) in the region of 
the -hole, denoted as VS,max. Results obtained in vacuo, diethylether and water 
are shown (Figure 59 left, centre and right, respectively).  In all cases, it is 
evident a negative correlation, according to results already reported by Politzer 
for a series of halogen bonded dimers [149] [148] [150], including in particular 
brominated benzenes and pyrimidines [193], indicating explicitly that a more 
pronounced -hole determines a stronger halogen bond. This is also confirmed 
by the IO distances (Figure 59, bottom), which tended as well to decrease with 
increasing of VS,max. The presence of the solvent gave rise to a shifting of the 
curves towards lower interaction energies and shorter IO distances. The same 
behaviour was obtained at the DFT level for both functionals. 
The previous considerations have been made by considering the 
variations of the electrostatic potential on the 0.001 au isosurface of electron 
density. It can be interesting also to analyze how the electrostatic potential 
changes moving away from this isosurface. 
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In Figure 60, some positive contour lines of the electrostatic potential 
are reported superimposed with the 0.001 au contour line of the electron 
density, on the plane of the phenyl group of two compounds, namely p-amino-
iodobenzene and pentafluorobenzene, in vacuo (Figure 60a and Figure 60b) 
and in water (Figure 60c and Figure 60d). From both vacuum and solvent 
results, it is well evident the different extension of the protuberance in the C–I 
region outside the space delimited by the 0.001 au electron density isosurface: it 
is quite limited for p-amino-iodobenzene, which gives rise to the weaker 
halogen-bonded dimer (Figure 60a and Figure 60c), while increases 
considerably along the C–I bond for pentafluorobenzene, which is associated to 
the stronger interaction (Figure 60b and Figure 60d). Clearly, the extension of 
such protuberance is strictly connected to the extension of the -hole. Such 
representation makes however more evident why larger - holes give rise not 
Figure 59 Plots of the I…O distance and interaction energy E versus VS,max, the maximum value 
assumed by the electrostatic potential on the isosurface of electron density (0.001 au) in the region of 
the sigma hole, calculated in vacuo (a, d), diethylether (b, e) and water (c, f) at MP2 level. 
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 only to stronger interactions, but also to C–IO angles closer to linearity. 
Stronger halogen bond donors are in fact able to ‘capture’ Lewis basis at longer 
distances with respect to weaker donor, making more favourable the linear 
approach between the interacting species. 
 
 
Figure 60 Positive contour lines (from 0.01 to 0.05 au) of the electrostatic potential superimposed 
with the 0.001 au contour line of the electron density, on the plane of the phenyl group of p-amino-
iodobenzene and pentafluorobenzene, in vacuo (a, b) and in water (c, d). 
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The problem of representing halogen bonds in molecular mechanics can 
be solved by simply introducing a pseudo-atom, i.e. an extra point located 
along the D–X bond, allowing to adequately fit the anisotropy of the 
electrostatic potential around halogen atoms. By using this approach, it was 
possible to properly describe the behaviour of halogenated ligands in complex 
with an extended series of known proteins, providing results in close agreement 
with crystallographic structures and with results of more expensive QM/MM 
calculations.  The  results therefore indicated that traditional force fields can be 
still used to describe halogen bond interactions, provided that such a simple 
modification is introduced in the force field itself. The need of introducing 
pseudo atoms was confirmed by the results obtained by the same simulations 
performed in the absence of the pseudo atoms. Using the native force field, in 
fact, halogen bonds either were poorly described, assuming very distorted 
Conclusions 
Part III 
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geometries, or disappeared completely throughout the simulation. The 
improvement obtained using the pseudo-atom approach can thus be valuable in 
the field of rational design of new halogenated drugs. 
A systematic study on the solvent effect on halogen bonding was also 
performed through calculations at the MP2 and DFT level on a series of IO 
halogen-bonded complexes of variously substituted iodobenzene with 
formaldehyde. The effect of two solvents, i.e. diethylether and water, on the 
energetical and geometrical aspects of the interaction, have been investigated 
by comparison with results obtained in vacuo. The different substitution 
schemes on iodobenzene were used as a simple way to modulate the strength of 
the interaction from weak to moderate halogen bonds. It turned out that solvent 
acts in a systematic way on both geometry and strength of halogen bonding, 
implying, from one side, a shortening of the IO distance and a greater 
tendency to linearity of the C–IO angle, and, from the other side, a decrease of 
the interaction energy. Such effects were found to increase with the polarity of 
the solvent. Though halogen bonding appears then to be destabilized in solvent 
with respect to the gas phase, it plays anyway a fundamental role in biological 
systems, in synergy or even in competition with hydrogen bond.  
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